Continuous cultures of fused cells secreting antibody of predefined specificity View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1975-08

AUTHORS

G. KÖHLER, C. MILSTEIN

ABSTRACT

THE manufacture of predefined specific antibodies by means of permanent tissue culture cell lines is of general interest. There are at present a considerable number of permanent cultures of myeloma cells1,2 and screening procedures have been used to reveal antibody activity in some of them. This, however, is not a satisfactory source of monoclonal antibodies of predefined specificity. We describe here the derivation of a number of tissue culture cell lines which secrete anti-sheep red blood cell (SRBC) antibodies. The cell lines are made by fusion of a mouse myeloma and mouse spleen cells from an immunised donor. To understand the expression and interactions of the Ig chains from the parental lines, fusion experiments between two known mouse myeloma lines were carried out. More... »

PAGES

495-497

Journal

TITLE

Nature

ISSUE

5517

VOLUME

256

Related Patents

  • Methods Of Identifying Latent Splice Sites
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Scd Fingerprints
  • Lung Cancer Biomarkers
  • Human Anti-B7rp1 Neutralizing Antibodies
  • Bh3 Peptides And Method Of Use Thereof
  • Method For Antiphospholipid Syndrome
  • Phosphospecific Chemokine Receptor Antibodies
  • Compositions And Methods For Cancer
  • Luca2 And Antibodies That Bind Thereto
  • Human Fetal Bladder-Derived Epithelial Cells
  • Compositions And Methods For Screening And Using Compounds Antagonizing Spore-Surface Interactions
  • Therapy Targeting Flt4 (Veger-3) Expressed In Blood Vessels
  • Antibodies Directed Against Amyloid-Beta Peptide And Methods Using Same
  • Anti-Lymphotoxin
  • Immobilized Immunoglobulin-Binding Proteins
  • High Affinity Monoclonal Antibodies To Bowman-Birk Inhibitor And Immunoassay Methods
  • Monoclonal Antibody That Recognizes A Structure Common To Human Interleukin-2 (Tcgf) And To The Light Lambda Chain Of Human Immunoglobulin And Lines Of Hybridoma Cells That Produce These Monoclonal Antibodies
  • Chromatin Regulator Genes
  • Method Of Detecting Native Probnp
  • Polyalkylene Oxide-Modified Single Chain Polypeptides
  • Methods For Making Compositions Including Gram Negative Microbial Polypeptides
  • Methods For Generating Or Increasing Revenues From Crops
  • Inhibitors Of Autophosphorylation Protein Kinases
  • Human Vanilloid Receptor Vr3 Protein
  • Monoclonal Antibodies Reactive With Human Breast Cancer
  • Egvi Endoglucanase And Nucleic Acids Encoding The Same
  • Methods And Reagents For Determining Protein S
  • Bgl4 Β-Glucosidase And Nucleic Acids Encoding The Same
  • Lysin-Deficient Bacteriophages Having Reduced Immunogenicity
  • Proteins Encoded By Polynucleic Acids Of Porcine Reproductive And Respiratory Syndrome Virus (Prrsv)
  • Modified Adamts4 Molecules And Method Of Use Thereof
  • Dnas Encoding Guinea Pig Histamine Receptors Of The H4 Subtype
  • Sulfotransferase Sequence Variants
  • Nucleotide Sequence Of Mammastatin And Methods Of Use
  • Human Pancreatic Epithelial Progenitor Cells And Methods Of Isolation And Use Thereof
  • Active Immunization Using A Siderophore Receptor Protein
  • Mutations Associated With Iron Disorders
  • Apo-2 Ligand
  • Substitutional Variants Of Apo-2 Ligand
  • Method For The Analysis Of Soluble Analytes
  • Methods Of Inhibiting Osteoclastogenesis
  • Human Chromogranin A (Cga) Immunologic Assay, Antibodies, Reagents And Kits For Said Assay
  • Method For Targeted Delivery Of Nucleic Acids
  • Monoclonal Antibodies Against Human Protein Mcm3, Process For Their Production, And Their Use
  • Host Defense Enhancement
  • Nuclear Matrix Protein Fluid Assay
  • Metal Ion-Ligand Coordination Complexes, Antibodies Directed Thereto, And Assays Using Such Antibodies
  • Methods Of Obtaining Compositions Enriched For Hematopoietic Stem Cells, Compositions Derived Therefrom And Methods Of Use Thereof
  • Process For Inhibiting Complement Activation Via The Alternative Pathway
  • Chimeric Mammals With Human Hematopoietic Cells
  • Interleukin-1 Receptor Antagonist And Recombinant Production Thereof
  • Methodologies For The Detection Of Human Immunodeficiency Virus Nucleic Acids Employing Oligonucleotide Primer Derived From The Hiv-1 Mvp5180/91 Genome
  • Methods And Materials Relating To Cd39-Like Polypeptides
  • Anti-Ige Antibodies And Method Of Improving Polypeptides
  • Lipoprotein Lipase Suppression By Endotoxin-Induced Mediator (Shock Assay)
  • Identification Of Agents That Protect Against Inflammatory Injury To Neurons
  • Anticancer Compounds And Methods
  • Down-Regulation And Silencing Of Allergen Genes In Transgenic Peanut Seeds
  • Streptococcus Pneumoniae Proteins And Nucleic Acid Molecules
  • Antigen Constructs Useful In The Detection And Differentiation Of Antibodies To Hiv
  • Method Of Identifying Compounds That Modulate Human Histamine H3 Receptor
  • Detection Of Hypoxia
  • Methods For Producing Members Of Specific Binding Pairs
  • Human Kinase And Polynucleotides Encoding The Same
  • Antibody To Aminoterminal Propeptide Of Type 1 Procollagen, And Assay Method Using It
  • Treatment For Inflammatory Bowel Disease With Vla-4 Blockers
  • Β3 Integrin Subunit Specific Polypeptides, Cdnas Which Encode These Polypeptides And Methods Of Producing These Polypeptides
  • Immunological Detection Method
  • Hme1 Nucleic Acids And Probes
  • Aminoterminal Propeptides Of Typed 1 Procollagen
  • Anti-Αvβ3 Integrin Antibody Antagonists
  • Polymorphisms In The Human Gene For The Multidrug Resistance-Associated Protein 1 (Mrp-1) And Their Use In Diagnostic And Therapeutic Applications
  • Klebsiella Antigens
  • Human Telomerase Catalytic Subunit
  • Modified Plasminogen Activator Inhibitor Type-1 Molecule And Methods Based Thereon
  • B. Anthracis Prevention And Treatment: Mutant B. Anthracis Lacking Luxs Activity And Furanone Inhibition Of Growth, Ai-2 Quorum Sensing, And Toxin Production
  • Immune-Compromised Transgenic Mice Expressing Human Hepatocyte Growth Factor (Hhgf)
  • Collectin
  • Tes7 And Antibodies That Bind Thereto
  • Therapeutic Method For Reducing Angiogenesis
  • Nucleic Acid Molecules Encoding Transmembrane Serine Proteases, The Encoded Proteins And Methods Based Thereon
  • Methods For The Diagnosis And Treatment Of Epilepsy
  • Immunoglobulins Devoid Of Light Chains
  • Tumor Associated Antigen, Peptides Thereof, And Use Of Same As Anti-Tumor Vaccines
  • Transgenic Mice Expressing Antibodies Specific For Genes Of Interest And Uses Thereof
  • Method And Kits For Detecting Cerebrospinal Fluid In A Sample
  • Antibody To Telomerase Reverse Transcriptive
  • Soluble Hyaluronidase Glycoprotein (Shasegp), Process For Preparing The Same, Uses And Pharmaceutical Compositions Comprising Thereof
  • Human Anti-Opgl Neutralizing Antibodies As Selective Opgl Pathway Inhibitors
  • Multiple Signaling Pathways Induced By Hexavalent, Monospecific And Bispecific Antibodies For Enhanced Toxicity To B-Cell Lymphomas And Other Diseases
  • Neutralizing Anti-Influenza A Virus Antibodies And Uses Thereof
  • Quantitation Of Cellular Dna And Cell Numbers Using Element Labeling
  • Bifunctional Histone Deacetylase Inhibitors
  • Antibodies Directed Against Amyloid-Beta Peptide And Methods Using Same
  • Chimeric Vegf Peptides
  • Methods, Antibodies And Kits For Detecting Cerebrospinal Fluid In A Sample
  • S-Adenosyl-L-Methionine Analogs With Extended Activated Groups For Transfer By Methyltransferases
  • Cd44 Polypeptides, Polynucleotides Encoding Same, Antibodies Directed Thereagainst And Method Of Using Same For Diagnosing And Treating Inflammatory Diseases
  • Micropatterning Of Molecular Surfaces Via Selective Irradiation
  • Cytotoxic Compounds And Conjugates
  • Diagnostic Method For Epilepsy
  • Methods For Modifying Surfaces
  • Plant Centromere Compositions
  • Arl-1 Specific Antibodies
  • Compositions And Methods For The Therapy And Diagnosis Of Influenza
  • Treatment Of Celiac Disease With Iga
  • Preprimitive Streak And Mesendoderm Cells
  • Circovirus Sequences Associated With Piglet Weight Loss Disease (Pwd)
  • Lymphokine In The Pure State, Monoclonal Antibodies, Hybridoma Cell Lines, Processes And Applications
  • Monoclonal Antibody Against Human Manganese-Superoxide Dismutase, Method For Producing The Monoclonal Antibody, Assay Reagent Or Assay Kit And Assay Method By Use Thereof, And Diagnostic Method Of Human Ovarian Cancer And Myocardial Infarction By Use Thereof
  • Monoclonal Antibodies To Anthracyclines
  • Methods For Treating Progressive Multiple Sclerosis
  • Methods For Treating Conditions Associated With Masp-2 Dependent Complement Activation
  • Simultaneous Imaging, Monitoring, And Therapy
  • Anti-Cxcl1, Cxcl7 And Cxcl8 Antibodies And Their Applications
  • Constructs Targeting Afp Peptide/Mhc Complexes And Uses Thereof
  • Antibody-Sn-38 Immunoconjugates With A Cl2a Linker
  • Cell-Permeable Probes For Identification And Imaging Of Sialidases
  • Engineered Antibodies And Other Fc-Domain Containing Molecules With Enhanced Agonism And Effector Functions
  • Methods Of Treatment Using Antibodies Which Bind Il-17a And Il-17f
  • Isolation Of Adult Multipotential Cells By Tissue Non-Specific Alkaline Phosphatase
  • Monoclonal Antibodies Specific For Serogroup W Of N. Meningitidis And Uses Thereof In Diagnosis
  • Anti-Hepcidin Antibodies And Uses Thereof
  • Albumin Binding Antibodies And Binding Fragments Thereof
  • Antibody Producing Non-Human Mammals
  • Hydrophilic Self-Immolative Linkers And Conjugates Thereof
  • Modified J-Chain
  • Method To Generate Antibodies To Ion Channels
  • Modified Caspase Polypeptides And Uses Thereof
  • Antibodies Capable Of Binding To The Coagulation Factor Xi And/Or Its Activated Form Factor Xia And Uses Thereof
  • Antibodies To Risperidone Haptens And Use Thereof
  • Treatment Of Cancer By Manipulation Of Commensal Microflora
  • Generation Of Binding Molecules
  • Lamin A, An Activator Of Longevity/Anti-Aging Sirt1 Protein
  • Rm2 Antigens And Use Thereof
  • Diagnosis Of Liver Pathology Through Assessment Of Protein Glycosylation
  • Automatic Image Playback
  • Method Of Screening For Compounds That Disaggregate Amyloid Aggregates
  • Antibody Molecules Which Bind Il-17a And Il-17f
  • Heparanase Specific Molecular Probes And Their Use In Research And Medical Applications
  • Cytotoxicity Mediation Of Cells Evidencing Surface Expression Of Cd44
  • Methods For Treating Obesity Using Fibroblast Growth Factor-Like Polypeptides
  • Antibodies That Bind Specifically To Phosphorylated Β-Catenin
  • Chimeric Vegf Peptides
  • Severe Acute Respiratory Syndrome Dna Compositions And Methods Of Use
  • Progenitor Endothelial Cell Capturing With A Drug Eluting Implantable Medical Device
  • Methods Of Screening For Neoplastic Disease States
  • Vesiculins
  • Avirulent, Immunogenic Flavivirus Chimeras
  • Variant Hypocrea Jecorina Cbh1 Cellulase
  • Bgl7 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Adam-9 Modulators
  • Recombinant Glycoproteins Related To Feline Thyrotropin
  • Compositions And Methods For The Therapy And Diagnosis Of Influenza
  • Antibody Molecules Having Specificity For Human Il-6
  • Nucleic Acids Encoding Class Ii Human Histone Deacetylases, And Uses Related Thereto
  • Induced Activation In Dendritic Cells
  • Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
  • Γ-Secretase Substrates And Methods Of Use
  • Method For The Treatment Of T Cell Mediated Conditions By Depletion Of Icos-Positive Cells In Vivo
  • Compositions And Methods For The Therapy And Diagnosis Of Influenza
  • Aptamers Against The Myelin Basic Protein As Neuroprotective Agents
  • Antibodies And Pharmaceutical Compositions Containing Same Useful For Inhibiting Activity Of Metalloproteins
  • 4-1bb Binding Molecules
  • Human Rhinovirus (Hrv) Antibodies
  • Ephb3-Specific Antibody And Uses Thereof
  • Methods For Detecting Antibody That Specifically Bind A Siderophore Receptor Polypeptide
  • Inhibitors Of The Epidermal Growth Factor Receptor-Heat Shock Protein 90 Binding Interaction
  • Soluble Glycosaminoglycanases And Methods Of Preparing And Using Soluble Glycosaminoglycanases
  • Therapeutic Use Of Anti-Cd22 Antibodies For Inducing Trogocytosis
  • Modified Polynucleotides For The Production Of Secreted Proteins
  • Human G-Protein Chemokine Receptor Hsatu68
  • Bcrf1 Antagonists For Treating Epstein-Barr Virus Infections
  • Method For Diagnosing Neurodegenerative Diseases
  • Methods Of Immuno-Analysis Using Monoclonal Antibodies
  • Monoclonal Antibody And Process For Its Preparation
  • Methods For Inhibiting The Binding Of Endosialin To Ligands
  • Regulatable Growth Of Filamentous Fungi
  • Methods For Treating Bone Cancer Pain By Administering A Nerve Growth Factor Antagonist
  • Class- And Isoform-Specific Hdac Inhibitors And Uses Thereof
  • Bgl7 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Targeted Thrombosis
  • Knockout Animals Manifesting Hyperlipidemia
  • Compositions And Methods For Treating Cancer By Modulating Her-2 And Egf Receptors
  • Composition And A Reagent For Ctla - 4, And Uses Thereof
  • Parenterally Administrable Drug Having Thrombolytic Activity And Containing Protein C
  • Immunological Detection Method
  • Monoclonal Antibodies For Differentiating Pathogenic And Nonpathogenic E. Histolytica
  • Inhibitors Of Platelet Binding
  • Sequential Peptide And Oligonucleotide Syntheses Using Immunoaffinity Techniques
  • Oncolytic Viruses And Methods For Treating Neoplastic Disorders
  • Engineered Nucleic Acids Encoding A Modified Erythropoietin And Their Expression
  • Cdna Encoding A Gene Bog (B5t Over-Expressed Gene) And Its Protein Product
  • Genes Associated With Posttraumatic-Stress Disorder (Ptsd)
  • Lipid Membrane Structure Containing Anti-Mt-Mmp Monoclonal Antibody
  • Cellular Permissivity Factor For Viruses, And Uses Thereof
  • Bgl5 Β-Glucosidase And Nucleic Acids Encoding The Same
  • Anti-Hepcidin Antibodies And Uses Thereof
  • Diagnostic Antibody Assay
  • Metal Ion-Ligand Coordination Complexes, Antibodies Directed Thereto, And Assays Using Such Antibodies
  • Producing Immunogenic Constructs Using Soluble Carbohydrates Activated Via Organic Cyanylating Reagents
  • Purification Of Human Chorionic Gonadotropin Β-Core Molecule And Preparation Of Antibodies With Specificity For Same
  • Monoclonal Antibodies To Pdgf
  • Hybridomas Producing Monoclonal Antibodies Specific For Felv P27
  • Assays For Detecting Antibodies Specific To Therapeutic Anti-Ige Antibodies And Their Use In Anaphylaxis
  • Method For Measurement Of Hepatitis C Virus
  • Method For Detection Of Methylthioadenosine Phosphorylase Deficiency In Mammalian Cells
  • Antibody Producing Non-Human Mammals
  • Hydrophilic Self-Immolative Linkers And Conjugates Thereof
  • Modified J-Chain
  • Method To Generate Antibodies To Ion Channels
  • Filip1l Nucleic Acid Fragments
  • Histone Deacetylases, And Uses Related Thereto
  • Anti-Trop-2 Antibody-Drug Conjugates And Uses Thereof
  • Perlecan Fragments As Biomarkers Of Bone Stromal Lysis
  • Allelic Disorders Caused By Mutations In Trpv4
  • Avirulent, Immunogenic Flavivirus Chimeras
  • Infectious Clone Of Human Parvovirus B19 And Methods
  • Live Cell Biosensors
  • Antigen Constructs Useful In The Detection And Differentiation Of Antibodies To Hiv
  • Compositions And Methods For Treating Cancer By Modulating Her-2 And Egf Receptors
  • Targeted Delivery To Legumain-Expressing Cells
  • Detection And Modulation Of Cancer Stem Cells
  • Cytotoxicity Mediation Of Cells Evidencing Surface Expression Of Cd44
  • Diagnosis Of Liver Pathology Through Assessment Of Protein Glycosylation
  • Epha2 As A Therapeutic Target For Cancer
  • Antigen Constructs Useful In The Detection And Differentiation Of Antibodies To Hiv
  • Streptococcus Pyogene Antigens
  • Antibodies To Oncostatin M Receptor
  • Transferrin Receptor Antibodies
  • A Long Qt Syndrome Gene Which Encodes Kvlqt1 And Its Association With Mink
  • Isolating Human Antibodies
  • Glycated Cd59 Peptides, Their Preparation, And Uses Thereof
  • Anti-Cd74 Immunoconjugates And Methods Of Use
  • Methods For Ligation And Uses Thereof
  • Aβ Conformer Selective Anti-Aβ Globulomer Monoclonal Antibodies
  • Single Chain Trimers And Uses Therefor
  • Histone Deacetylase And Tubulin Deacetylase Inhibitors
  • Human Anti-B7rp1 Neutralizing Antibodies
  • Hybrid Expression Of Neisserial Proteins
  • Human Monoclonal Antibodies To Human Nucleolin
  • Flavivirus Detection Methods Employing Recombinant Antigens Comprising A Japanese Encephalitis (Jev) Signal Sequence
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Cross-Screening System And Methods For Detecting A Molecule Having Binding Affinity For A Target Molecule
  • Method Of Enriching For Pancreatic Endoderm Cells
  • Multi-Component Inhibitors Of Nucleic Acid Polymerases
  • Methods For Measuring Platelet Reactivity Of Individuals Treated With Drug Eluting Stents
  • Cd44 Polypeptides, Polynucleotides Encoding Same, Antibodies Directed Thereagainst And Method Of Using Same For Diagnosing And Treating Inflammatory Diseases
  • Egvii Endoglucanase And Nucleic Acids Encoding The Same
  • Hybrid Cell Line For Producing Monoclonal Antibody To A Human Prothymocyte Antigen, Antibody, Method Of Preparation Of This Antibody, Diagnostic And Therapeutic Uses, And Pharmaceutical Compositions Comprising This Antibody
  • Hybrid Cell Line For Producing Monoclonal Antibody To A Human Early Thymocyte Antigen, Antibody, Method Of Preparation Of This Antibody, Diagnostic And Therapeutic Uses And Pharmaceutical Compositions Comprising This Antibody
  • Uncharacterized Orf3 In Sars-Coronavirus Is A Cyclic-Amp-Dependent Kinase And A Target For Sars Therapy
  • Diagnostic And Therapeutic Epitope, And Transgenic Plant
  • Amino Acid Sequence Presenting Fusion Polypeptide And Its Use
  • An Antibody Specifically Binding To Insulin-Like Growth Factor-1
  • Immunizing Compositions And Methods Of Use
  • Human Cytomegalovirus Neutralising Antibodies And Use Thereof
  • Antibody-Sn-38 Immunoconjugates With A Cl2a Linker
  • Notch1 Receptor Binding Agents And Methods Of Use Thereof
  • T-Cell Receptor Cdr3 Peptides And Antibodies
  • Anti-Human Vegf Antibodies With Unusually Strong Binding Affinity To Human Vegf-A And Cross Reactivity To Human Vegf-B
  • Unsymmetrical Pyrrolobenzodiazepines-Dimers For Use In The Treatment Of Proliferative And Autoimmune Diseases
  • Pan-Selectin Inhibitor With Enhanced Pharmacokinetic Activity
  • Cd47 Antibodies And Methods Of Use Thereof
  • Monoclonal Antibodies That Bind B7h6 And Uses Thereof
  • Identification Of Agents For Treating Calcium Disorders And Uses Thereof
  • Identification Of Antigen Or Ligand-Specific Binding Proteins
  • Class Ii Human Histone Deacetylases, And Uses Related Thereto
  • Methods And Compositions For The Generation And Use Of Conformation-Specific Antibodies
  • Diagnosis Of Liver Pathology Through Assessment Of Anti-Gal Igg Glycosylation
  • Antibody-Sn-38 Immunoconjugates With A Cl2a Linker
  • Methods And Compositions For Diagnosing Osteoarthritis In A Feline
  • Method Of Producing 4-1bb Binding Molecules And Associated Nucleic Acids
  • Isolation, Detection, Diagnosis And/Or Characterization Of Circulating Trop-2-Positive Cancer Cells
  • Novel C3c Epitope, Antibodies Binding Thereto, And Use Thereof
  • Fgf21 Polypeptides Comprising Two Or More Mutations
  • Method For The Prognosis And Treatment Of Cancer Metastasis
  • Compositions Relating To A Mutant Clostridium Difficile Toxin And Methods Thereof
  • Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
  • Anti-Ed-A Immunoconjugates For Inflammatory Bowel Disease
  • Methods Of Testing Cancer Cells And Anticancer Drugs
  • Method For Preparing Monoclonal Antibody To Hbsag
  • Monoclonal Anti-Idiotype Antibodies
  • Human Monoclonal Antibodies Against Bacterial Toxins
  • Vertebrate Smoothened Antibodies
  • Active Immunization Using A Siderophore Receptor Protein
  • Method To Determine Metastatic Potential Of Tumor Cells
  • An Anti-Hiv Protein, Tap 29, From Trichosanthes, Dna Coding Therefor And Therapeutic Uses Thereof
  • Monoclonal Antibody Against Human Manganese-Superoxide Dismutase, Method For Producing The Monoclonal Antibody, Assay Reagent Or Assay Kit And Assay Method By Use Thereof, And Diagnostic Method Of Human Ovarian Cancer And Myocardial Infarction By Use Thereof
  • Monoclonal Antibodies To Anthracyclines
  • Lysin-Deficient Bacteriophages Having Reduced Immunogenicity
  • Polyalkylene Oxide-Modified Single Chain Polypeptides
  • Methods For Making Compositions Including Gram Negative Microbial Polypeptides
  • Modified Adamts4 Molecules And Method Of Use Thereof
  • Dnas Encoding Guinea Pig Histamine Receptors Of The H4 Subtype
  • Methods For Generating Or Increasing Revenues From Crops
  • Inhibitors Of Autophosphorylation Protein Kinases
  • Human Vanilloid Receptor Vr3 Protein
  • Immunogenic Compositions For The Prevention And Treatment Of Meningococcal Disease
  • Methods And Compounds For Detection Of Molecular Targets
  • Filip1l Nucleic Acid Fragments
  • Cytotoxicity Mediation Of Cells Evidencing Surface Expression Of Cd44
  • Diagnosis Of Liver Pathology Through Assessment Of Protein Glycosylation
  • Epha2 As A Therapeutic Target For Cancer
  • Streptococcus Pyogene Antigens
  • Induced Activation In Dendritic Cells
  • Avirulent, Immunogenic Flavivirus Chimeras
  • Automatic Stent Detection
  • Methods And Compositions For Synthesis Of Nucleic Acid Molecules Using Multiple Recognition Sites
  • Encapsulation Of Pancreatic Cells Derived From Human Pluripotent Stem Cells
  • Methods For Generating Radioimmunoconjugates
  • Ddr1-Binding Agents And Methods Of Use Thereof
  • Human Monoclonal Antibodies To Human Nucleolin
  • Compositions And Methods For Diagnosing And Treating Phenylketonuria (Pku)
  • Identification Of Agents For Treating Calcium Disorders And Uses Thereof
  • Identification Of Antigen Or Ligand-Specific Binding Proteins
  • Diagnostic And Therapeutic Epitope, And Transgenic Plant
  • Amino Acid Sequence Presenting Fusion Polypeptide And Its Use
  • An Antibody Specifically Binding To Insulin-Like Growth Factor-1
  • Methods And Assays For Measuring P95 And/Or P95 Complexes In A Sample And Antibodies Specific For P95
  • Method For Producing Antigen-Specific Antibodies Via In Vitro Immunisation
  • Class Ii Human Histone Deacetylases, And Uses Related Thereto
  • Immunizing Compositions And Methods Of Use
  • Human Cytomegalovirus Neutralising Antibodies And Use Thereof
  • Antibody-Sn-38 Immunoconjugates With A Cl2a Linker
  • Aβ Conformer Selective Anti-Aβ Globulomer Monoclonal Antibodies
  • Methods And Compositions For Diagnosing Osteoarthritis In A Feline
  • Histone Deacetylases, And Uses Related Thereto
  • Method Of Producing 4-1bb Binding Molecules And Associated Nucleic Acids
  • Perlecan Fragments As Biomarkers Of Bone Stromal Lysis
  • Production Of Proteins In Glutamine-Free Cell Culture Media
  • Monoclonal Antibody Therapy For Pancreas Cancer
  • T-Cell Receptor Cdr3 Peptides And Antibodies
  • Notch1 Receptor Binding Agents And Methods Of Use Thereof
  • Telescopic Side Port Catheter Device With Imaging System And Method For Accessing Side Branch Occlusions
  • Anti-Cd74 Immunoconjugates And Methods Of Use
  • Methods For Ligation And Uses Thereof
  • Novel C3c Epitope, Antibodies Binding Thereto, And Use Thereof
  • Fgf21 Polypeptides Comprising Two Or More Mutations
  • Isolation, Detection, Diagnosis And/Or Characterization Of Circulating Trop-2-Positive Cancer Cells
  • Histone Deacetylase And Tubulin Deacetylase Inhibitors
  • Glycated Cd59 Peptides, Their Preparation, And Uses Thereof
  • Avirulent, Immunogenic Flavivirus Chimeras
  • Allelic Disorders Caused By Mutations In Trpv4
  • Human Fgf Receptor And Β-Klotho Binding Proteins
  • Single Chain Trimers And Uses Therefor
  • Methods And Compositions For The Generation And Use Of Conformation-Specific Antibodies
  • Anti-Human Vegf Antibodies With Unusually Strong Binding Affinity To Human Vegf-A And Cross Reactivity To Human Vegf-B
  • Metal Ion-Ligand Coordination Complexes, Antibodies Directed Thereto, And Assays Using Such Antibodies
  • Producing Immunogenic Constructs Using Soluble Carbohydrates Activated Via Organic Cyanylating Reagents
  • Purification Of Human Chorionic Gonadotropin Β-Core Molecule And Preparation Of Antibodies With Specificity For Same
  • Monoclonal Antibodies To Pdgf
  • Hybridomas Producing Monoclonal Antibodies Specific For Felv P27
  • Acute Leukemia And Lymphoblastic Lymphoma-Specific Cd43 Epitope And Use Thereof
  • Conjugates Of Cell Binding Molecules With Cytotoxic Agents
  • Method For Detection Of Methylthioadenosine Phosphorylase Deficiency In Mammalian Cells
  • Isolating Human Antibodies
  • Anti-Trop-2 Antibody-Drug Conjugates And Uses Thereof
  • Alpha-Fetoprotein Immu31 Antibodies And Fusion Proteins And Methods Of Use Thereof
  • Active Immunization Using A Siderophore Receptor Protein
  • Cytotoxicity Mediation Of Cells Evidencing Surface Expression Of Cd44
  • Peptide Nanostructures Encapsulating A Foreign Material And Method Of Manufacturing Same
  • Method To Determine Metastatic Potential Of Tumor Cells
  • An Anti-Hiv Protein, Tap 29, From Trichosanthes, Dna Coding Therefor And Therapeutic Uses Thereof
  • Compositions Comprising Chimeric Ospa Molecules And Methods Of Use Thereof
  • Diagnosis Of Liver Pathology Through Assessment Of Anti-Gal Igg Glycosylation
  • Antibody-Sn-38 Immunoconjugates With A Cl2a Linker
  • Anti-Ed-A Immunoconjugates For Inflammatory Bowel Disease
  • Methods For Detecting Oncofetal Fibronectin
  • Anti-T. Cruzi Antibodies And Methods Of Use
  • Vertebrate Smoothened Antibodies
  • Methods Of Testing Cancer Cells And Anticancer Drugs
  • Deacetylase Inhibitors And Uses Thereof
  • Application Of Mrna For Use As A Therapeutic Against Tumor Diseases
  • Method For Preparing Monoclonal Antibody To Hbsag
  • Monoclonal Anti-Idiotype Antibodies
  • Human Monoclonal Antibodies Against Bacterial Toxins
  • Camptothecin Conjugates Of Anti-Cd22 Antibodies For Treatment Of B Cell Diseases
  • Antibodies To Receptor For Advanced Glycation End Products (Rage) And Uses Thereof
  • Combination Treatment Of Pancreatic Cancer
  • Assays For Detecting Antibodies Specific To Therapeutic Anti-Ige Antibodies And Their Use In Anaphylaxis
  • Non-Lipidated Variants Of Neisseria Meningitidis Orf2086 Antigens
  • Therapeutic Dll4 Binding Proteins
  • Means And Methods For Diagnosing Cancer Using An Antibody Which Specifically Binds To Braf V600e
  • Tet2 As A New Diagnostic And Pronostic Marker In Hematopoietic Neoplasms
  • Unsymmetrical Pyrrolobenzodiazepines-Dimers For Use In The Treatment Of Proliferative And Autoimmune Diseases
  • Pan-Selectin Inhibitor With Enhanced Pharmacokinetic Activity
  • Method For Measurement Of Hepatitis C Virus
  • Immunogenic Compositions For The Prevention And Treatment Of Meningococcal Disease
  • Methods And Means For The Production Of Ig-Like Molecules
  • Cd47 Antibodies And Methods Of Use Thereof
  • Monoclonal Antibodies That Bind B7h6 And Uses Thereof
  • Microbubbles For Affinity Separation
  • Mutations In Ion Channels
  • Bgl7 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Compositions And Methods For Treatment Of Severe Acute Respiratory Syndrome (Sars)
  • Assays For Cancer Patient Monitoring Based On Levels Of Analyte Components Of The Plasminogen Activator System In Body Fluid Samples
  • Mhc-Peptide Complex Binding Ligands
  • Anti-Ngf Antibodies And Methods Using Same
  • Soluble Glycosaminoglycanases And Methods Of Preparing And Using Soluble Glycosaminoglycanases
  • Inhibitors Of Complement Activation
  • Human Kunitz-Type Inhibitor With Enhanced Antifibrinolytic Activity
  • Methods For Prognosticating Progression Or Long Term Non-Progression Of A Hiv Infection Or Hiv-Associated Disorders In A Patient
  • Method Of Using A Polynucleotide Encoding 2.5-Diketo-D-Gluconic Acid Reductase
  • Nucleic Acids Coding For Adhesion Factors Of Group B Streptococcus, Adhesion Factors Of Group B Streptococcus And Futher Uses Thereof
  • Diagnostic And Therapeutic Applications Of Soluble Lhcgr Protein
  • Process For The Production Of Monoclonal Antibodies
  • Flavivirus Immunogens Comprising Extracellular Viral Particles Composed Of The Premembrane (Prm) And Envelope (E) Antigens
  • Prostate Cancer Diagnosis And Treatment
  • Detection Of Human Antibodies To Squalene In Serum
  • Recombinant Anti-Vla4 Antibody Molecules
  • Soluble Glycosaminoglycanases And Methods Of Preparing And Using Soluble Glycosaminoglycanases
  • Prostate Cancer Diagnosis And Treatment
  • Compositions And Methods For The Treatment And Prevention Of Hyperproliferative Diseases
  • Egvi Endoglucanase And Nucleic Acids Encoding The Same
  • Method Of Detecting A Subfraction Of Probnp
  • Method For Screening A Library Of Vhh Polypeptides
  • Use Of The Transcription Of The Slug Gene In Evaluating The Redisposition Of A Subject With Cancer To Develop Metastatis
  • Angiogenesis Inhibiting Molecules And Their Use In The Treatment And Diagnosis Of Cancer
  • Compositions And Methods For Cancer
  • Methods Of Use Of Antibodies Which Recognize A Protease Cleavage Site Of An Lap Fragment Of Tgf-Β
  • Methods For Treating Bone Cancer Pain By Administering A Nerve Growth Factor Antagonist Antibody
  • Method For The Diagnosis And Prognosis Of Malignant Diseases
  • Methods For Treating Obesity Using Fibroblast Growth Factor-Like Polypeptides
  • Modified Amylases From Pseudomonas Species
  • Basb006 Polynucleotide(S) And Polypeptides From Neisseria Meningitis
  • Cystine Knot Molecules
  • Her-2 Binding Antagonists
  • Human Monoclonal Antibodies Against Hendra And Nipah Viruses
  • Gastrin Hormone Immunoassays
  • Nucleic Acids Encoding Chimeric Flavivirus Immunogens Comprising The Japanese Encephalitis Virus (Jev) Prm Signal Sequence
  • Circovirus Sequences Associated With Piglet Weight Loss Disease (Pwd)
  • Antibodies Directed Against Amyloid-Beta Peptide And Nucleic Acids Encoding Same
  • Soluble Erbb3 Methods Of Detection And Antibodies
  • Antibodies That Bind To Cancer-Associated Antigen Cd46 And Methods Of Use Thereof
  • Regulatable Growth Of Filamentous Fungi
  • Nephropathy-Associated Gene
  • Soluble Erbb3 And Treatment Of Cancer
  • Immunoglobulins Devoid Of Light Chains
  • Influenza Virus Vaccine Composition And Methods Of Use
  • Assays For Cancer Patient Monitoring Based On Levels Of Analyte Components Of The Plasminogen Activator System In Body Fluid Samples
  • Mhc-Peptide Complex Binding Ligands
  • Compositions And Methods For Treatment Of Severe Acute Respiratory Syndrome (Sars)
  • Correction Of Alpha-1-Antitrypsin Genetic Defects Using Spliceosome Mediated Rna Trans Splicing
  • Peptide Nanostructures And Methods Of Generating And Using The Same
  • Biomarkers Of Liver Injury
  • Cellular Permissivity Factor For Viruses And Uses Thereof
  • Anti-Cd20 Antibodies And Fusion Proteins Thereof And Methods Of Use
  • Methods For Detecting Targets
  • Combination Therapy With Anti-Cd74 Antibodies Provides Enhanced Toxicity To Malignancies, Autoimmune Disease And Other Diseases
  • Method Of Providing Disease-Specific Binding Molecules And Targets
  • Human Serum Albumin Linkers And Conjugates Thereof
  • Binding Polypeptides And Uses Thereof
  • Immunogenic Compositions For The Prevention And Treatment Of Meningococcal Disease
  • Monoclonal Antibodies That Bind B7h6 And Uses Thereof
  • Antibody Molecules Having Binding Specificity For Human Il-13
  • Sgp130/Fc Dimers
  • Light Emitting Microorganisms And Cells For Diagnosis And Therapy Of Tumors
  • Data Structure Of An Image Storage And Retrieval System
  • Cell Culture Compositions
  • Methods And Systems For Using Rfid In Biological Field
  • Methods And Systems For Using Rfid In Biological Field
  • Anti-Pd-L1 Antibodies And Uses Therefor
  • Variant Hypocrea Jercorina Cbh1 Cellulases
  • Klebsiella Antigens
  • Fgf21 Mutants Multimers And Uses Thereof
  • Collectin
  • Bcr-Abl1 Splice Variants And Uses Thereof
  • Methods Of Determining Patient Response By Measurement Of Her-3
  • Aegyptin And Uses Thereof
  • Antibodies That Recognize Cutting Edge Within The Tgf-Β Activation Controlling Region
  • Methods, Products And Treatments For Diabetes
  • Homeobox Gene
  • Chimeric Polypeptides And Uses Thereof
  • Compounds
  • Light Emitting Microorganisms And Cells For Diagnosis And Therapy Of Diseases Associated With Wounded Or Inflamed Tissue
  • Peptide-Based Passive Immunization Therapy For Treatment Of Atherosclerosis
  • Variant Hyprocrea Jecorina Cbh1 Cellulases
  • Soluble Glycosaminoglycanases And Methods Of Preparing And Using Soluble Glycosaminoglycanases
  • Human Antibodies Specific For Gastrin Materials And Methods
  • Soluble Hyaluronidase Glycoprotein (Shasegp), Process For Preparing The Same, Uses And Pharmaceutical Compositions Comprising Thereof
  • Carbonic Anhydrase Ix (G250) Anitbodies
  • Antibodies That Bind To Epha2 And Methods Of Use Thereof
  • Monoclonal Antibodies To Progastrin
  • Transgenic Non-Human Animals For Producing Chimeric Antibodies
  • Compositions And Methods For Binding Lysophosphatidic Acid
  • Anti-Plgf Antibody
  • Methods And Compositions For Detection Of Ehrlichia Chaffeensis (P120)
  • System And Method Of Registering Field Of View
  • Compositions And Methods For Angiogenesis-Related Molecules And Treatments
  • Anti-Ngf Antibodies And Methods Using Same
  • Biomarker For Replicative Senescence
  • Predictive Marker Of Dnmt1 Inhibitor Therapeutic Efficacy And Methods Of Using The Marker
  • Bgl7 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Antibodies To Il-1 R1 And Methods Of Making Them
  • Synthesis And Intermediates Of Pyrrolobenzodiazepine Derivatives For Conjugation
  • Gene And Mutations Thereof Associated With Seizure And Movement Disorders
  • Membrane Evaporation For Generating Highly Concentrated Protein Therapeutics
  • Cereblon Isoforms And Their Use As Biomarkers For Therapeutic Treatment
  • Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
  • Application Of Mrna For Use As A Therapeutic Against Tumour Diseases
  • Application Of Mrna For Use As A Therapeutic Against Tumour Diseases
  • Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
  • Multispecific Antibodies
  • Human Inkt Cell Activation Using Glycolipids With Altered Glycosyl Groups
  • Markers For The Prediction Of Outcome Of Anthracycline Treatment
  • Methods For Treating, Diagnosing, And Monitoring Lupus
  • Methods For Inhibiting The Binding Of Endosialin To Ligands
  • Circovirus Sequences Associated With Piglet Weight Loss Disease (Pwd)
  • Method Of Treatment For Leukemia Using An Anti-Il1rap Antibody
  • Method Of Treating A Solid Tumor With Il1rap Antibodies
  • Variant Enzymes
  • Methods For Modifying Human Antibodies By Glycan Engineering
  • Neutralizing Monoclonal Antibodies Against The Nogo-66 Receptor (Ngr) And Uses Thereof
  • Methods For The Treatment Of Cancer And Inflammatory Diseases Using Cereblon As A Predictor
  • Pyrrolobenzodiazepine-Antibody Conjugates
  • Compositions Produced Using Enteric Pathogens And Methods Of Use
  • Nt-Procnp As A Biomarker Of Vascular Disorders And Pregnancy Complication
  • Pyrrolobenzodiazepine-Antibody Conjugates
  • Proteins With Modified Glycosylation And Methods Of Production Thereof
  • Cross-Reactive Staphylococcus Aureus Antibody
  • Methods For Inducing Partial Apoptosis Using Caspase Polypeptides
  • Methods And Compositions For Prostate Cancer Metastasis
  • Pyrrolobenzodiazepine—Antibody Conjugates
  • Isolated Dna Sequences Encoding, And Methods For Making, Antibody Molecules Having Binding Specificity For Human Il-13
  • Anti-Alpha Synuclein Binding Molecules
  • Trem2 Cleavage Modulators And Uses Thereof
  • 88kda Tumorigenic Growth Factor And Antagonists
  • Methods Of Producing Immunoglobulins, Vectors And Transformed Host Cells For Use Therein
  • Method Of Using Cd2-Binding Domain Of Lymphocyte Function Associated Antigen 3 To Initiate T Cell Activation
  • Monoclonal Antibody To Human Glicentin, Hybridoma For Producing Said Antibody And Assay Method For Human Glicentin Using Said Antibody
  • Human Monoclonal Antibody Neutralizing Vascular Endothelial Growth Factor Receptor And Use Thereof
  • Modified Polynucleotides Encoding Cited4
  • New Methods For Treatment Of Inflammatory Diseases
  • Modified Polynucleotides For The Production Of Nuclear Proteins
  • Methods And Kits For Diagnosing Tumorigenicity
  • Modified Polynucleotides Encoding Septin-4
  • Automatic Calibration Systems And Methods Of Use
  • Methods Of Treating Cancer Using Pd-1 Axis Binding Antagonists And Mek Inhibitors
  • Bcr-Abl Variants
  • Use Of Nucleoside Derivatives Comprising A Citrate Group For The Production Of Antibodies Having An Affinity For Triphosphorylated Nucleosides
  • Tcr-V-Beta Related Peptides For Treatment And Diagnosis Of Autoimmune Disease
  • Method For Production Of Bioresorbable Microparticles, Microparticles Thus Obtained And Use Thereof
  • Mutant Citrobacter Freundii Phytase Polypeptide
  • Variant Buttiauxella Sp. Phytases Having Altered Properties
  • Isolated Antibodies Against Biologically Active Leptin-Related Peptides
  • Antibodies Recognizing A Carbohydrate Containing Epitope On Cd-43 And Cea Expressed On Cancer Cells And Methods Using Same
  • Cetp Fragments
  • Hla-Restricted, Peptide-Specific Antigen Binding Proteins
  • Methods For Increasing Definitive Endoderm Production
  • Methods For Assessing Responsiveness Of B-Cell Lymphoma To Treatment With Anti-Cd40 Antibodies
  • Bcr-Abl1 Splice Variants And Uses Thereof
  • Mutant Protein Capable Of Binding Specifically And Quickly To Troponin I Derived From Human Myocardium
  • Plants Modified With Mini-Chromosomes
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Methods And Systems For Transforming Luminal Images
  • Human Anti-Pd-1 Antibodies And Uses Therefor
  • Modulators Of Intracellular Chloride Concentration For Treating Down Syndrome
  • Avirulent, Immunogenic Flavivirus Chimeras
  • Antigen-Presenting Complex-Binding Compositions And Uses Thereof
  • Pharmaceutical Compositions That Modulate Hptpbeta Activity
  • Affinity Structures For The Specific Binding Of Substances By Not - Covalent Showed Interaction Forms
  • Raag10 Cell Surface Target And A Family Of Antibodies Recognizing That Target
  • Mutant 2,5-Diketo-L-Gluconic Acid Reductases
  • Recombinant Bifunctional Protein Of Human Lutropin Receptor And Human Chorionic Gonadotropin B-Subunit And Uses Thereof
  • Induction Of Apoptosis And Cell Growth Inhibition By Protein 4.33
  • Differentially Expressed Tumour-Specific Polypeptides For Use In The Diagnosis And Treatment Of Cancer
  • Use Of A Polypeptide For Detecting, Preventing Or Treating A Pathological Condition Associated With A Degenerative, Neurological Or Autoimmune Disease
  • Cancer Biomarkers
  • Bacterium Causing Poultry Disease And Vaccine Derived Thereof
  • Antibodies To The Human Prolactin Receptor
  • Compositions And Methods For The Rapid Growth And Detection Of Microorganisms
  • Preparing Hapten-Specific Antibodies And Their Application For Immunodiagnostics And Research
  • Uses Of Fgf21 Polypeptides Comprising Two Or More Mutations
  • Antibodies Against Cxcr4 And Methods Of Use Thereof
  • Methods Of Modulating Immune Function
  • Hyaluronidase And Factor Viii Compositions
  • Soluble Hyaluronidase Glycoprotein (Shasegp), Process For Preparing The Same, Uses And Pharmaceutical Compositions Comprising Thereof
  • Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
  • Hcv Ns3 Recombinant Antigens And Mutants Thereof For Improved Antibody Detection
  • Chimeric Ospa Genes, Proteins And Methods Of Use Thereof
  • Compositions And Methods For Growth Factor Modulation
  • Cyclic Peptides As Adam Protease Inhibitors
  • Biomarkers For Type 2 Diabetes
  • Iconic Communication
  • Anti-Cmet Antibody
  • Compositions For Inhibiting Masp-2 Dependent Complement Activation
  • Fusion Constructs And Use Of Same To Produce Antibodies With Increased Fc Receptor Binding Affinity And Effector Function
  • Methods For Determining Drug Efficacy Using Cereblon-Associated Proteins
  • Bh3 Peptides And Method Of Use Thereof
  • Tuberculosis Vaccines Comprising Antigens Expressed During The Latent Infection Phase
  • Antibodies With Immune Effector Activity And That Internalize In Endosialin-Positive Cells
  • Methods For Making Antibody Molecules Having Specificity For Human Il-6
  • Anti-Mesothelin Antibodies
  • Clec14a Inhibitors
  • Amyloid Precursor-Like Protein And Uses Thereof
  • Producing Immunogenic Constructs Using Soluble Carbohydrates Activated Via Organic Cyanylating Reagents
  • Bovine Leptin Protein, Nucleic Acid Sequences Coding Therefor And Uses Thereof
  • Methods Of Inhibiting Type 2 Vascular Endothelial Growth Factor Receptors Using Polypeptides
  • Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
  • Compositions And Methods For Growth Factor Modulation
  • Cyclic Peptides As Adam Protease Inhibitors
  • Biomarkers For Type 2 Diabetes
  • Compositions Produced Using Enteric Pathogens And Methods Of Use
  • Antibodies Against Cxcr4 And Methods Of Use Thereof
  • Compositions For Inhibiting Masp-2 Dependent Complement Activation
  • Methods For Making Antibody Molecules Having Specificity For Human Il-6
  • Bispecific Egfr/Igfir Binding Molecules
  • Use Of A Polypeptide For Detecting, Preventing Or Treating A Pathological Condition Associated With A Degenerative, Neurological Or Autoimmune Disease
  • Pdes And Uses Thereof
  • Icbp90 Polypeptide And Its Fragments And Polynucleotides Coding For Said Polypeptides And Applications For Diagnosing And Treating Cancer
  • Apo-2 Ligand
  • Compositions And Methods For Regulating Autolytic Processes In Bacteria
  • Efficient Synthesis Of Protein-Oligonucleotide Conjugates
  • Methods Of Immuno Analysis Using Monoclonal Antibodies
  • Anti Cxcr4 Antibodies And Their Use For The Treatment Of Cancer
  • Down-Regulation And Silencing Of Allergen Genes In Transgenic Peanut Seeds
  • Tes7 And Antibodies That Bind Thereto
  • Anti-Htra1 Antibodies And Methods Of Use
  • Compositions And Methods For Modulating Dnmt1 Inhibitor Activity
  • Monoclonal Antibody Against Pentacyclic Oleanan-Type Triterpene And Use Thereof
  • Producing Monoclonal Antibodies Against Human T-Cell Receptor Elements Using Recombinant Dna Vectors
  • Producing Monoclonal Antibodies Against Human T-Cell Receptor Elements Using Recombinant Dna Vectors.
  • Method For Reducing Adverse Effects Of A Human 70kda Mediator Which Results From Endotoxin Stimulation Of Macrophages
  • Apo-2-Receptor
  • Cloned Dna Encoding Mammalian Occludins
  • Actinium-225 Complexes And Conjugates For Targeted Radiotherapy
  • Prodrugs Activated By Targeted Catalytic Proteins
  • 2,5-Diketo-L-Gluconic Acid Reductases And Methods Of Use
  • Polynucleotide And Polypeptide Sequences Of Monkey Cathepsin S
  • Methods And Compositions Relating To Cd39-Like Polypeptides And Nucleic Acids
  • Cdna Encoding A Gene Bog (B5t Over-Expressed Gene) And Its Protein Product
  • Flt4 (Vegfr-3) As A Target For Tumor Imaging And Anti-Tumor Therapy
  • Polyalkylene Oxide-Modified Single Chain Polypeptides
  • Antigenic Material, Antibodies Raised Thereto, Hybridomas For Producing Antibodies, And Immunoassays Incorporating Such Antibodies
  • Modulation Of Drug Resistance Via Ubiquitin Carboxy-Terminal Hydrolase
  • Protein-Polysaccharide Conjugate Vaccines And Other Immunological Reagents Prepared Using Homobifunctional And Heterobifunctional Vinylsulfones, And Processes For Preparing The Conjugates
  • Monoclonal Antibody And Antigens Specific Therefor And Methods Of Using Same
  • Method For Targeted Delivery Of Nucleic Acids
  • Methods And Compositions Relating To Cd39-Like Polypeptides And Nucleic Acids
  • Sulfonylurea Receptor Trangenic Rodents
  • Tyramine Compounds And Their Neuronal Effects
  • Preparation Of Factor Ix
  • Anti-Ige Antibodies And Methods Of Improving Polypeptides
  • Method Of Producing Aminoterminal Propeptide Of Type 1 Procollagen
  • Phage-Display Of Immunoglobulin Heavy Chain Libraries
  • Cd2-Binding Domain Of Lymphocyte Function Associated Antigen-3
  • Antibodies Against A Host Cell Antigen Complex For Pre And Post Exposure Protection From Infection By Hiv
  • Bcrf1 Antagonists For Treating Epstein-Barr Virus Infections
  • Use Of Protein C Or The Activation Peptide Of Protein C For Preparing A Pharmaceutical Preparation
  • Immunological Detection Methods
  • Peptide Library Formats And Methods Relating Thereto
  • Immunoassays Empolying Generic Anti-Hapten Antibodies And Materials For Use Therein
  • Composition Containing The P40 Subunit Of Interleukin-12
  • Metal Ion-Ligand Coordination Complexes, Antibodies Directed Thereto, And Assays Using Such Antibodies
  • Metal Ion-Ligand Coordination Complexes, Antibodies Directed Thereto, And Assays Using Such Antibodies
  • Methods For The Production Of Antibodies And Induction Of Immune Responses To Tumor-Associated Gangliosides By Immunization With Ganglioside Lactones
  • Variant Enzymes
  • Methods For Modifying Human Antibodies By Glycan Engineering
  • Markers For The Prediction Of Outcome Of Anthracycline Treatment
  • Methods For Treating, Diagnosing, And Monitoring Lupus
  • Methods For Inhibiting The Binding Of Endosialin To Ligands
  • Circovirus Sequences Associated With Piglet Weight Loss Disease (Pwd)
  • Method Of Treatment For Leukemia Using An Anti-Il1rap Antibody
  • Method Of Treating A Solid Tumor With Il1rap Antibodies
  • Neutralizing Monoclonal Antibodies Against The Nogo-66 Receptor (Ngr) And Uses Thereof
  • Methods For The Treatment Of Cancer And Inflammatory Diseases Using Cereblon As A Predictor
  • Pyrrolobenzodiazepine-Antibody Conjugates
  • Compositions Produced Using Enteric Pathogens And Methods Of Use
  • Cross-Reactive Staphylococcus Aureus Antibody
  • Methods For Inducing Partial Apoptosis Using Caspase Polypeptides
  • Methods And Compositions For Prostate Cancer Metastasis
  • Nt-Procnp As A Biomarker Of Vascular Disorders And Pregnancy Complication
  • Pyrrolobenzodiazepine-Antibody Conjugates
  • Proteins With Modified Glycosylation And Methods Of Production Thereof
  • Bgl7 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Pyrrolobenzodiazepine—Antibody Conjugates
  • Isolated Dna Sequences Encoding, And Methods For Making, Antibody Molecules Having Binding Specificity For Human Il-13
  • Anti-Alpha Synuclein Binding Molecules
  • Synthesis And Intermediates Of Pyrrolobenzodiazepine Derivatives For Conjugation
  • Trem2 Cleavage Modulators And Uses Thereof
  • Human Inkt Cell Activation Using Glycolipids With Altered Glycosyl Groups
  • Gene And Mutations Thereof Associated With Seizure And Movement Disorders
  • Methods For Converting Glucose To Ascorbic Acid
  • Chimeric Mammals With Human Hematopoietic Cells
  • Antihuman Stromelysin Monoclonal Antibody And Diagnosis Of Rheumatoid Arthritis By Enzyme Immunoassay
  • Virulence-Attenuating Genetic Deletions
  • Serum Albumin Binding Molecules
  • Hcv Core Lipid Binding Domain Monoclonal Antibodies
  • Cancer Biomarkers
  • Bacterium Causing Poultry Disease And Vaccine Derived Thereof
  • B. Anthracis Prevention And Treatment: Mutant B. Anthracis Lacking Luxs Activity And Furanone Inhibition Of Growth, Ai-2 Quorum Sensing, And Toxin Production
  • Antibodies To Opgl
  • Compositions And Methods For Identifying Agents Which Regulate Autolytic Processes In Bacteria
  • Dnas Encoding Rat Histamine Receptors Of The H4 Subtype
  • Methods For Treating Mastitis In A Milk Producing Animal
  • Histone Deacetylases, And Uses Related Thereto
  • Iconic Communication
  • Binding Proteins That Bind To Human Fgfr1c, Human Β-Klotho And Both Human Fgfr1c And Human Β-Klotho
  • Methods For Detecting Oncofetal Fibronectin
  • Crh Responsive Genes In Cns
  • Human Medical Treatment By Aerosol Inhalation Of Immunoglobulin A
  • New Mammal Protein Having An Immunomodulating And Progestational Activity
  • Immunoassay Method For Small Molecules
  • Transgenic Organisms And Cells, And Methods Of Producing Transgenic Organisms And Cells
  • Modified Polynucleotides For Treating Protein Deficiency
  • Csf3r Polypeptides And Uses Thereof
  • Combination Of Angiopoietin-2 Antagonist And Of Vegf-A, Kdr And/Or Flt1 Antagonist For Treating Cancer
  • Method Of Assaying Immunization Stimulating Activity
  • Methods For The Production Of Antibodies And Induction Of Immune Responses To Tumor-Associated Ganagliosides By Immunization With Gangloiside Lactones
  • Antibody Reactive To Hamster Immunoglobulins And Assay Using Same
  • Antibodies To A4 Amyloid Peptide
  • Monoclonal Anti-Alpha-Amylase Antibody Which Non-Specifically Inhibits The Enzyme Activity Of Human Alpha-Amylase
  • Compositions Relating To A Mutant Clostridium Difficile Toxin And Methods Thereof
  • Progenitor Endothelial Cell Capturing With A Drug Eluting Implantable Medical Device
  • Transgenic Non-Human Animals For Producing Chimeric Antibodies
  • Microporous Materials, Methods Of Making, Using, And Articles Thereof
  • Regulatable Growth Of Filamentous Fungi
  • Artificial Cell Constructs For Cellular Manipulation
  • Reactive Labelling Compounds And Uses Thereof
  • Methods For Testing Anti-Thrombotic Agents
  • Antibodies To Risperidone And Use Thereof
  • Methods Of Treating Cancer By Administering An Axl Ligand-Binding Portion Of An Axl Tyrosine Kinase Receptor Extracellular Domain
  • Monoclonal Antibody To Human Helper T Cells, Method Of Preparing It, Hybrid Cell Line Producing It, Its Diagnostic And Therapeutic Uses And Diagnostic And Therapeutic Compositions Comprising It
  • Hybrid Cell Line For Producing Monoclonal Antibody To A Human Monocyte Antigen, Antibody, And Methods
  • Methods And Reagents For Diagnosing Rheumatoid Arthrtis
  • Antibodies To The E1 Extracellular Loop Of Ion Channels
  • Methods And Systems For Transforming Luminal Images
  • Fusion Constructs And Use Of Same To Produce Antibodies With Increased Fc Receptor Binding Affinity And Effector Function
  • Iconic Communication
  • Fgf 21 Polypeptides Comprising Two Or More Mutations And Uses Thereof
  • Antibodies With Immune Effector Activity And That Internalize In Endosialin-Positive Cells
  • Methods For Identifying And Isolating Cells Expressing A Polypeptide
  • Nucleic Acids Encoding Inactive Variants Of Human Telomerase
  • Antibodies With Immune Effector Activity And That Internalize In Endosialin-Positive Cells
  • Uses Of Fgf21 Polypeptides Comprising Two Or More Mutations
  • Cynomolgus Gp80 Receptor And Uses Thereof
  • Immunizing Composition And Method For Inducing An Immune Response Against The Beta-Secretase Cleavage Site Of Amyloid Precursor Protein
  • Neisseria Meningitidis Compositions And Methods Thereof
  • Anti-Idiotypic Antibody And Its Use In Diagnosis And Therapy In Hiv-Related Disease
  • Producing Immunogenic Constructs Using Soluable Carbohydrates Activated Via Organic Cyanylating Reagents
  • Anti-Asialo-Gm1 Monoclonal Antibodies And Method Of Use
  • Mutant Protein Capable Of Binding Specifically And Quickly To Troponin I Derived From Human Myocardium
  • Plants Modified With Mini-Chromosomes
  • Methods For Early Detection Of Heart Disease
  • Modified Sendai Virus Vaccine And Imaging Vector
  • Monoclonal Antibodies To Placental Isoferritin For Use In Detecting Oncofetal Ferritin Associated With Breast Cancer And Hodgkins Disease
  • Glycan-Interacting Compounds And Methods Of Use
  • Compositions And Methods For The Treatment Of Sepsis
  • Selective Binding Agents Of Telomerase
  • Automated System For Combining Bright Field And Fluorescent Microscopy
  • Anti-Angiogenic Therapy
  • Bcr-Abl1 Splice Variants And Uses Thereof
  • Human Anti-Pd-1 Antibodies And Uses Therefor
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Compositions Produced Using Enteric Pathogens And Methods Of Use
  • Monoclonal Antibodies That Specifically Block Biological Activity Of A Tumor Antigen
  • Conjugate Molecules
  • Human Monoclonal Anti-Pd-L1 Antibodies And Methods Of Use
  • Method Of Treating A Patient For Pain By Administering An Anti-Ion Channel Antibody
  • Anti-Igf-Ir Antibodies And Uses Thereof
  • Stem Cell Factor Inhibitor
  • Assay For Cardiac Troponin-T (Ctnt)
  • Methods For Preparing Sequencing Libraries
  • Methods Of Purifying Anti A Β Antibodies
  • Compositions And Methods For Treating Pigmentary Conditions And Melanoma
  • Antibodies Recognizing A Carbohydrate Containing Epitope On Cd-43 And Cea Expressed On Cancer Cells And Methods Using Same
  • Delivery And Formulation Of Engineered Nucleic Acids
  • Allelic Disorders Caused By Mutations In Trpv4
  • Porcine Circovirus Type 2 Vaccines
  • Methods And Compositions Relating To Cd39-Like Polypeptides And Nucleic Acids
  • Combination Therapy With Anti-Cd74 And Anti-Cd20 Antibodies Provides Enhanced Toxicity To B-Cell Diseases
  • Antibody Drug Conjugates (Adc) That Bind To Cd37 Proteins
  • Polypeptides And Use Thereof
  • Modified Polynucleotides For The Production Of Proteins Associated With Human Disease
  • Antibody Cocktail
  • Immunogenic Fusion Polypeptides
  • Biomarkers For Systemic Lupus Erythematosus
  • Stable Formulations Of Neisseria Meningitidis Rlp2086 Antigens
  • Delivery And Formulation Of Engineered Nucleic Acids
  • Use Of Dr6 And P75 Antagonists To Promote Survival Of Cells Of The Nervous System
  • Diagnostic And Therapeutic Target For Autoimmune Diseases And Uses Thereof
  • Egvii Endoglucanase And Nucleic Acids Encoding The Same
  • Medical Device With Coating For Capturing Genetically-Altered Cells And Methods For Using Same
  • Antibodies Reactive With B7-H3, Immunologically Active Fragments Thereof And Uses Thereof
  • Decreasing Lactate Level And Increasing Polypeptide Production By Downregulating The Expression Of Lactate Dehydrogenase And Pyruvate Dehydrogenase Kinase
  • Bispecific Molecules That Are Immunoreactive With Immune Effector Cells Of A Companion Animal That Express An Activating Receptor And Cells That Express B7-H3 And Uses Thereof
  • Compositions Comprising Polyglutamic Acid Nanoparticles And Cd40 Agonists
  • Cell Growth-Promoting Peptide And Use Thereof
  • Inhibitors Of Type 2 Vascular Endothelial Growth Factor Receptors
  • Combination Of Human Cytomegalovirus Neutralizing Antibodies
  • Method Of Treating Cardiac Arrhythmia With Long Acting Atrial Natriuretic Peptide(La-Anp)
  • Targeting Construct Comprising Anti-Polymer Antibody And Contrast/Therapeutic Agents Binding To The Same
  • Assay For Measurement Of Antibodies Binding To A Therapeutic Monoclonal Antibody
  • Human Chondroitinase Glycoprotein (Chasegp), Process For Preparing The Same, And Pharmaceutical Compositions Comprising Thereof
  • Compositions And Methods For The Therapy And Diagnosis Of Influenza
  • Multiple Signaling Pathways Induced By Hexvalent, Monospecific And Bispecific Antibodies For Enhanced Toxicity To B-Cell Lymphomas And Other Diseases
  • Nucleic Acid Molecule Encoding A Specific Il-1r1 Antibody
  • Stable Compositions For Nucleic Acid Amplification And Sequencing
  • Cellular Permissivity Factor For Viruses And Uses Thereof
  • Compositions And Methods For The Treatment Of Tumor Of Hematopoietic Origin
  • Methods Of Generating High-Production Of Antibodies From Hybridomas Created By In Vitro Immunization
  • Plant Artificial Chromosome (Plac) Compositions And Methods
  • Mcsp-Aligned Scfv Antibody Fragments And Use Of Same
  • Immunizing Compositions And Methods Of Use
  • Immunizing Compositions And Methods Of Use
  • Anti-Cd26 Antibodies And Methods Of Use Thereof
  • Methods And Compositions For Synthesis Of Nucleic Acid Molecules Using Multiple Recognition Sites
  • Antibodies Directed To Angiopoietin-1 And Angiopoietin-2 And Uses Thereof
  • Cytotoxicity Mediation Of Cells Evidencing Surface Expression Of Cd44
  • Tumor Necrosis Factor-Gamma
  • Antibodies Recognizing A Carbohydrate Containing Epitope On Cd-43 And Cea Expressed On Cancer Cells And Methods Using Same
  • Methods For Producing Members Of Specific Binding Pairs
  • Branched Molecular Scaffolds For Linking Polymer Residues To Biologically Active Moieties
  • Antibodies To Gm-Csf
  • Methods For Inhibiting The Binding Of Endosialin To Ligands
  • Therapeutic Targets In Cancer
  • Methods Of Treating Cancer Comprising Administering An Interleukin-6 Antibody Variable Region
  • Antibody Drug Conjugates (Adc) That Bind To Cd37 Proteins
  • Bgl6 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Therapeutic Use Of Anti-Cd22 Antibodies For Inducing Trogocytosis
  • Use Of Low Temperature And/Or Low Ph In Cell Culture
  • Anti-Ox40 Antibodies And Methods Of Use
  • Delivery And Formulation Of Engineered Nucleic Acids
  • A Method For The Preparation Of A Monoclonal Antibody Against Oligomeric Alpha - Synuclein
  • Compositions For Inhibiting Masp-2 Dependent Complement Activation
  • Ultrapurified Dsba And Dsbc And Methods Of Making And Using The Same
  • Class-And Isoform-Specific Hdac Inhibitors And Uses Thereof
  • Methods Of Improving Vaccine Immunogenicity
  • Methods And Compositions For Analyzing Proteins
  • Compositions Produced Using Enteric Pathogens And Methods Of Use
  • Antibody Cocktail
  • Albumin Binding Antibodies And Binding Fragments Thereof
  • Antibody Formulations
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Signal Biomarkers
  • Immunogenic Fusion Polypeptides
  • Biomarkers For Systemic Lupus Erythematosus
  • Multiple Signaling Pathways Induced By Hexvalent, Monospecific And Bispecific Antibodies For Enhanced Toxicity To B-Cell Lymphomas And Other Diseases
  • Compositions And Methods For The Therapy And Diagnosis Of Influenza
  • Human Chondroitinase Glycoprotein (Chasegp), Process For Preparing The Same, And Pharmaceutical Compositions Comprising Thereof
  • Circovirus Sequences Associated With Piglet Weight Loss Disease (Pwd)
  • Use Of Dr6 And P75 Antagonists To Promote Survival Of Cells Of The Nervous System
  • Ephb3-Specific Antibody And Uses Thereof
  • Nucleic Acid Molecule Encoding A Specific Il-1r1 Antibody
  • Stable Compositions For Nucleic Acid Amplification And Sequencing
  • Anti-Mesothelin Antibodies
  • Recombinant Protein Capable Of Binding Specifically And Quickly To Troponin I Derived From Human Myocardium
  • M-Csf-Specific Monoclonal Antibody And Uses Thereof
  • Assay For Diagnosis Of Cardiac Myocyte Damage
  • Methods And Systems For Using Rfid In Biological Field
  • Immunizing Compositions And Methods Of Use
  • Chimeric Ospa Genes, Proteins, And Methods Of Use Thereof
  • Chimeric Ospa Genes, Proteins, And Methods Of Use Thereof
  • Definitive Endoderm
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Surface Protein (Hbsag) Variant Of The Hepatitis B Virus
  • Methods For Decreasing Immune Response And Treating Immune Conditions
  • Assay For Cardiac Troponin Autoantibodies
  • Method For Producing Immortalised Antibodies-Secreting Cells
  • Methods For Purifying Endoderm And Pancreatic Endoderm Cells Derived From Human Embryonic Stem Cells
  • Chimeric Pcsk9 Proteins, Cells Comprising Same, And Assays Using Same
  • Pharmacodiagnostic Test Targeting Oncology And Neurodegeneration
  • Isolation Of Adult Multipotential Cells By Tissue Non-Specific Alkaline Phosphatase
  • Histone Deacetylase Inhibitors
  • Antibodies To Receptor Of Advanced Glycation End Products (Rage) And Uses Thereof
  • Monoclonal Antibodies - Idiotype - Antibody Ganglidiomab
  • Chimeric Flavivirus Immunogens Comprising The Japanese Encephalitis Virus (Jev) Prm Signal Sequence
  • Methods For Producing Members Of Specific Binding Pairs
  • Non-Competitive Immunoassay For Small Analytes
  • Kid31 And Antibodies That Bind Thereto
  • Cyclic Molecular Framework And Derivatives Thereof
  • Methods And Compositions For Producing An Enhanced Immune Response To A Human Papillomavirus Immunogen
  • Monoclonal Antibodies, Antigens And Diagnosis And Therapy Of Malignant Diseases
  • A Cd44vra Antibody And Diagnostic And Therapeutic Methods Using Same
  • Dioxanes And Uses Thereof
  • Combination Of Human Cytomegalovirus Neutralizing Antibodies
  • Method Of Treating Cardiac Arrhythmia With Long Acting Atrial Natriuretic Peptide(La-Anp)
  • Targeting Construct Comprising Anti-Polymer Antibody And Contrast/Therapeutic Agents Binding To The Same
  • Antibodies Reactive With B7-H3, Immunologically Active Fragments Thereof And Uses Thereof
  • Cell Growth-Promoting Peptide And Use Thereof
  • Assay For Measurement Of Antibodies Binding To A Therapeutic Monoclonal Antibody
  • Inhibitors Of Type 2 Vascular Endothelial Growth Factor Receptors
  • Egvii Endoglucanase And Nucleic Acids Encoding The Same
  • Diagnostic And Therapeutic Target For Autoimmune Diseases And Uses Thereof
  • Decreasing Lactate Level And Increasing Polypeptide Production By Downregulating The Expression Of Lactate Dehydrogenase And Pyruvate Dehydrogenase Kinase
  • Bispecific Molecules That Are Immunoreactive With Immune Effector Cells Of A Companion Animal That Express An Activating Receptor And Cells That Express B7-H3 And Uses Thereof
  • Compositions Comprising Polyglutamic Acid Nanoparticles And Cd40 Agonists
  • Polypeptides And Use Thereof
  • Stable Formulations Of Neisseria Meningitidis Rlp2086 Antigens
  • Medical Device With Coating For Capturing Genetically-Altered Cells And Methods For Using Same
  • Modified Polynucleotides For The Production Of Proteins Associated With Human Disease
  • Antibodies With Immune Effector Activity And That Internalize In Folate Receptor Alpha-Positive Cells
  • Carrier Molecules
  • Human Vanilloid Receptor Vr3 Protein
  • Avirulent, Immunogenic Flavivirus Chimeras
  • Anticancer Compounds And Methods
  • Compositions And Methods For The Detection And Treatment Of Methylthioadenosine Phosphorylase Deficient Cancers
  • Bacterial Xylanases
  • Antibodies That Specifically Bind Pms2
  • Substantially Pure Receptor Like Tgf-Β1 Binding Molecules And Uses Thereof
  • Mammalian Adipogenic Factors
  • Inhib, A Factor Which Inhibits Cytokine-Activated Leukocytes
  • New Proteins
  • Haptens, Tracers, Immunogens And Antibodies For 3-Phenyl-1-Adamantaneacetic Acids
  • Monoclonal Antibody To Nitrotyrosine, Methods For Diagnosis And Methods For Treatment Of Disease
  • Methods For Identifying And Isolating Cells Expressing A Polypeptide
  • Mitigating Tissue Damage And Fibrosis Via Latent Transforming Growth Factor Beta Binding Protein (Ltbp4)
  • Cd40-Related Receptor That Binds Cd40l
  • Nucleic Acids Encoding Rearranged Human Immunoglobulin Sequences From Transgenic Transchromosomal Mice
  • Assay Of Isomerised And/Or Optically Inverted Proteins And Protein Fragments
  • Methods For Reducing Fecal Shedding
  • Mutant 2.5-Diketo-L-Gluconic Acid Reductases
  • Methods Of Determining Cellular Chemosensitivity
  • Anti-Cd20 Antibodies And Fusion Proteins Thereof And Methods Of Use
  • Dnas Encoding Mammalian Histamine Receptor Of The H4 Subtype And Encoded Protein
  • Methods Of Use Of Dna Encoding A Human Histamine Receptor Of The H3 Subtype
  • Anti-Bv8 Antibodies And Uses Thereof
  • F11 Receptor (F11r) Antagonists As Therapeutic Agents
  • Purification Of Proteins With Cationic Surfactant
  • Polynucleotides Encoding Antibodies Directed Against Amyloid-Beta Peptide
  • Process For The Determination Of Inflammatory Processes And Pharmaceutical Compositions For The Treatment Thereof
  • Formulation And Delivery Of Plga Microspheres
  • Application Of Mrna For Use As A Therapeutic Against Tumour Diseases
  • Pyrrolobenzodiazepines And Conjugates Thereof
  • System And Method For Oct Depth Calibration
  • Fgf Mutants With Reduced Proteolysis And Aggregation
  • B7-H3l Cell Surface Antigen And Antibodies That Bind Thereto
  • Compositions And Methods Of Altering Cholesterol Levels
  • Cancer Platinum Resistance Detection And Sensitization Method
  • Sgp130/Fc Dimers For Treatment Of Inflammatory Disease
  • Antibodies Reactive With B7-H3 And Uses Thereof
  • Methods And Nucleic Acids For The Analysis Of Gene Expression Associated With The Development Of Prostate Cell Proliferative Disorders
  • Modified Dendritic Cells Having Enhanced Survival And Immunogenicity And Related Compositions And Methods
  • Means And Methods For Treating Or Preventing Brain Tumors Based On The Nuclear Receptor Tailless (Tlx)
  • Mass Spectrometric Methods And Products
  • Methods For Treating Progressive Multiple Sclerosis
  • Dipeptide Analogs For Treating Conditions Associated With Amyloid Fibril Formation
  • Methods For Treating Il-6 Mediated Diseases With Antibody Molecules Specific For Il-6
  • Antibodies Reactive With B7-H3, Immunologically Active Fragments Thereof And Uses Thereof
  • Method For Controlling O-Desulfation Of Heparin And Compositions Produced Thereby
  • Nucleic Acid Fragment Encoding An Nrps For The Biosynthesis Of Anthramycin
  • Compositions And Methods For Growth Factor Modulation
  • Lafora's Disease Gene
  • Methods For Inhibiting The Binding Of Endosialin To Ligands
  • Antibodies To Receptor Of Advanced Glycation End Products (Rage) And Uses Thereof
  • Human Kunitz-Type Inhibitor With Enhanced Antifibrinolytic Activity
  • Cytotoxicity Mediation Of Cells Evidencing Surface Expression Of Trop-2
  • Expression Control Using Variable Intergenic Sequences
  • Nucleic Acid Vaccines For Prevention Of Flavivirus Infection
  • Polyene Polyketides, Processes For Their Production And Their Use As A Pharmaceutical
  • Methods And Compounds For Modulating Male Fertility
  • Human Mullerian Duct-Derived Epithelial Cells And Methods Of Isolation And Uses Thereof
  • Plant Centromere Compositions
  • Cancerous Disease Modifying Antibodies
  • Hxhv Virus, Nucleic Material, Peptide Material And Uses
  • Methods Of Treating Disorders By Administration Of F11 Receptor Antagonists
  • Novel Compounds Derived From Neisseria Meningitidis
  • Light Emitting Microorganisms And Cells For Diagnosis And Therapy Of Tumors
  • Secreted Proteins
  • Antibodies Specific For Tgf-Beta And Methods For Treating Thereof
  • Human Antigen Binding Proteins That Bind Β-Klotho, Fgf Receptors And Complexes Thereof
  • Methods And Nucleic Acids For Analyses Of Cellular Proliferative Disorders
  • Compositions And Methods For Diagnosing And Treating Community-Acquired Methicillin-Resistant Staphylococcus Aureus
  • Anti-Cmet Antibody
  • Methods For Treating Edema By Administering A Soluble Hyaluronidase Glycoprotein (Shasegp)
  • Microorganisms For Therapy
  • Antibodies To Aripiprazole And Use Thereof
  • Fgf21 Mutants Comprising A Mutation At Position 98, 171 And/Or 180
  • Antibodies To Olanzapine And Use Thereof
  • Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (Pcsk9)
  • Targeting Metastasis Stem Cells Through A Fatty Acid Receptor (Cd36)
  • Fibronectin Based Scaffold Proteins Having Improved Stability
  • Hmg1 Antibody For Treating Inflammatory Conditions
  • Neukinase, A Downstream Protein Of Neuregulin
  • Microarrays And Uses Therefor
  • Peptides Directed For Diagnosis And Treatment Of Amyloid-Associated Diseases
  • Copd Diagnosis
  • Fgf-21 Mutants Comprising Polyethylene Glycol And Uses Thereof
  • Anti Eotaxin-2 Antibodies That Recognize Additional Ccr3-Binding Chemokines
  • Method Of Treating Age-Related Macular Degeneration Comprising Administering A Compstatin Analog
  • Hydrophilic Self-Immolative Linkers And Conjugates Thereof
  • Antibodies For The Treatment Of Hiv
  • Prostate-Specific Gene For Diagnosis, Prognosis And Management Of Prostate Cancer
  • Antigenic Material, Antibodies Raised Thereto, Hybridomas For Producing Antibodies, And Immunoassays Incorporating Such Antibodies
  • Monoclonal Antibody Against Pentacyclic Oleanan-Type Triterpene And Use Thereof
  • Human Ovarian Mesothelial Cells And Methods Of Isolation And Uses Thereof
  • Lysin-Deficient Bacteriophages Having Reduced Immunogenicity
  • Methods Of Assessing Wolframin Protein Activity
  • Tumor-Associated Marker
  • Mammalian Suv39h2 Proteins And Isolated Dna Molecules Encoding Them
  • Regulatable Growth Of Filamentous Fungi
  • Genes And Proteins Involved In The Biosynthesis Of Enediyne Ring Structures
  • Micropositioning Cells For Tissue Engineering
  • Recombinant Pr-3 And Assays Employing The Same
  • Compositions And Methods For Early Detection Of Heart Disease
  • Kits For Early Detection Of Heart Disease
  • Laser Inactivation Of Inhibitory Molecules In Central Nervous System Myelin
  • Identification Of Agents That Protect Against Inflammatory Injury To Neurons
  • 3′-Exonuclease, Production And Use Thereof
  • Methods And Materials Relating To Novel Cd39-Like Polypeptides
  • Methods And Materials Relating To Novel Cd39-Like Polypeptides
  • Antibody Hybrid Molecules And Process For Their Preparation
  • Monoclonal Antibodies Reactive With Shared Idiotypes On Human Antibodies To Native Dna From Patients With Systemic Lupus Erythematosus
  • Method For Removal Of Human Antibodies To Native Dna From Serum
  • Use Of Monoclonal Antibodies Against Bacterial Adhesins
  • Diagnosis And Treatment Of Ptp04 Related Disorders
  • Methods And Materials Relating To Novel Cd39-Like Polypeptides
  • Compositions And Methods Of Diagnosing, Monitoring, Staging, Imaging And Treating Mammary Gland Cancer
  • Methods And Compositions Relating To Cd39-Like Polypeptides And Nucleic Acids
  • Polynucleotide And Polypeptide Sequences Of Canine Cathepsin S
  • Methods And Compositions Relating To Cd39-Like Polypeptides And Nucleic Acids
  • Polyalkylene Oxide-Modified Single Chain Polypeptides
  • Methods Of Testing Cancer And Anticancer Drugs
  • Nuclear Matrix Protein Fluid Assay
  • Virulence-Attenuating Genetic Deletions Deleted From Mycobacterium Bcg
  • Reagents And Methods For The Detection And Quantification Of Testosterone In Fluid Samples
  • Methods Of Screening For Persistent Hyperinsulinemic Hypoglycemia Of Infancy
  • Phage-Display Of Immunoglobulin Heavy Chain Libraries For Identification Of Inhibitors Of Intracellular Constituents
  • Monospecific Antibodies Against A Subunit Of Fibrinogen
  • Metal Ion-Ligand Coordination Complexes, Antibodies Directed Thereto, And Assays Using Such Antibodies
  • Monoclonal Antibody To Human T Cells, Method For Preparing It, Hybrid Cell Line Producing It, Therapeutic Composition Comprising It And Diagnostic Method Using It
  • Method To Ameliorate Osteolysis And Metastasis
  • Assays For Shiga Toxin And Shiga-Like Toxins
  • Pulsatile Delivery Of Leptin Receptor Ligands
  • Monospecific Antibodies Against A Subunit Of Fibrinogen
  • Preparation Of Factor Ix
  • Method For Molecular Diagnosis Of Tumor Angiogenesis And Metastasis
  • Antibodies To Flt4, A Receptor Tyrosine Kinase And Uses Thereof
  • A Subject Of Mammal, Having, In Particular, An Immunomodulator Activity And Progestational, Antibodies, Their Preparation And Their Application
  • Preparation Of Factor Ix
  • Method For Making Monoclonal Antibodies And Cross-Reactive Antibodies Obtainable By The Method
  • Anti-Ige Antibodies And Method Of Improving Polypeptides
  • Targeted Contrast Agents For Diagnostic And Therapeutic Use
  • Antibodies To Human Cancer Nucleolar Antigen Pl20, Corresponding Cell Lines, And Their Preparation And Use In The Detection Of Human Cancer Cells
  • Method Of Control Leukocyte Extravasation
  • Method Of Dissolving Venous Thrombi Using Drug Containing Activated Protein C
  • Haptens, Tracers, Immunogens And Antibodies For 3-Phenyl-1-Adamantaneacetic Acids
  • Methods For Stimulating Hematopoietic Progenitors Using Hepatocyte Growth Factor And Lymphokines
  • Nucleic Acids Encoding Murine And Human Ah Receptors
  • Assays And Reagents For Amyloid Deposition
  • Monoclonal Antibody To Human Carcinomas
  • Chimeric Protein That Has A Human Rho Motif And Deoxyribonuclease Activity
  • Monoclonal Antibody, Measuring Method Of Glucosylated Protein By Utilizing The Monoclonal Antibody, And Kit Therefor
  • Therapeutic Use Of Anti-Cd22 Antibodies For Inducing Trogocytosis
  • Antimicrobial Peptide And Use Thereof
  • Controlled Platelet Activation To Monitor Therapy Of Adp Antagonists
  • Antibody Cocktail
  • Class Ii Human Histone Deacetylases, And Uses Related Thereto
  • Gastrin Hormone Immunoassays
  • Proteins Encoded By Polynucleic Acids Of Porcine Reproductive And Respiratory Syndrome Virus (Prrsv)
  • Antibodies To Human Programmed Death Receptor Pd-1
  • Par4 Inhibitor Therapy For Patients With Par4 Polymorphism
  • Methods And Compositions For Assessing Responsiveness Of B-Cell Lymphoma To Treatment With Anti-Cd40 Antibodies
  • Antibodies To Receptor For Advanced Glycation End Products (Rage) And Uses Thereof
  • Anti-Baff Antibodies
  • Compositions And Methods For Diagnosing And Treating Cancer
  • Method For Detection Of L523s Expression In Biological Samples
  • Antibody Molecules Having Specificity For Human Ox40
  • Stable Antibody Containing Compositions
  • Ror1-Binding Molecules, And Methods Of Use Thereof
  • Encapsulation Of Pancreatic Cells Derived From Human Pluripotent Stem Cells
  • Tumor Necrosis Factor-Gamma
  • Anti-Mesothelin Antibodies
  • 88kda Tumorigenic Growth Factor And Antagonists
  • Influenza Virus Vaccine Composition And Methods Of Use
  • Cytotoxicity Mediation Of Cells Evidencing Surface Expression Of Cd44
  • Autoantibody Enhanced Immunoassays And Kits
  • Compositions And Methods For The Therapy And Diagnosis Of Cytomegalovirus
  • Antigen Constructs Useful In The Detection And Differentiation Of Antibodies To Hiv
  • Immunoassay Method And Kit To Be Used Therein
  • Vascular Tumor Markers
  • Polyalkylene Oxide-Modified Single Chain Polypeptides
  • Thermostable Amylase Polypeptides, Nucleic Acids Encoding Those Polypeptides And Uses Thereof
  • Compositions And Methods For The Therapy And Diagnosis Of Influenza
  • Methods And Systems For Characterizing A Cellular Constituent Using Response Profiles
  • Fgf21 Mutants And Uses Thereof
  • Bgl3 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Peptides Derived From A Retrovirus Of The Hiv Group And Their Use
  • Soluble Glycosaminoglycanases And Methods Of Preparing And Using Soluble Glycosaminoglycanases
  • 2,5-Diketo-L-Gluconic Acid Reductases And Methods Of Use
  • Methods And Kits For Diagnosing Tumorigenicity And Determining Resistance To The Antineoplastic Effects Of Antiestrogen Therapy
  • Mass Spectrometric Methods And Products
  • Β-Trcp1, Β-Trcp2 And Rsk1 Or Rsk2 Inhibitors And Methods For Sensitizing Target Cells To Apoptosis
  • Antibodies, Recombinant Antibodies, Recombinant Antibody Fragments And Fusions Mediated Plant Disease Resistance Against Fungi
  • Compositions And Methods Relating To Stop-1
  • Use Of A Polypeptide To Detect, Prevent Or Treat A Pathological State Associated With A Degenerative, Neurological, Autoimmune Illness
  • Immuno-Pet Imaging Of Antibodies And Immunoconjugates And Uses Therefor
  • Modified Polynucleotides Encoding Copper Metabolism (Murr1) Domain Containing 1
  • Dock-And-Lock (Dnl) Complexes For Therapeutic And Diagnostic Use
  • Methods For Treating Hematopoietic Malignancies
  • Monoclonal Antibodies Against Hmgb1
  • Immunoassay Of Analytes In Samples Containing Endogenous Anti-Analyte Antibodies
  • Histone Deacetylases, And Uses Related Thereto
  • Anti Human Immunodeficiency Antibodies And Uses Thereof
  • Recombinant Antibodies Against Hepatitis C Virus And Methods Of Obtaining And Using Same
  • Detection And Quantitation Of Full-Length Thioredoxin (Trx) And Truncated Thioredoxin (Trx 80) In Complex Samples
  • Antigen Binding Protein And Its Use As Addressing Product For The Treatment Of Cancer
  • Compositions For Analyzing Proteins
  • Mutant 2.5-Diketo-L-Gluconic Acid Reductases
  • Anti-Cmet Antibody
  • Methods For Treating Edema By Administering A Soluble Hyaluronidase Glycoprotein (Shasegp)
  • Light Emitting Microorganisms And Cells For Diagnosis And Therapy Of Tumors
  • Secreted Proteins
  • Compositions Relating To A Mutant Clostridium Difficile Toxin And Methods Thereof
  • Neisseria Meningitidis Composition And Methods Thereof
  • Compositions And Methods Useful For Stabilizing Protein-Containing Formulations
  • Therapeutic Use Of Anti-Cd22 Antibodies For Inducing Trogocytosis
  • Monoclonal-Antibody-Producing Hybrid Cell Line, Antibody And Method Of Preparing It, Therapeutic Composition Containing It And Its Diagnostic And Therapeutic Uses
  • Monoclonal Antibody To Human Helper T Cells, Method Of Preparing It, Hybrid Cell Line Producing It, Its Diagnostic And Therapeutic Uses And Diagnostic And Therapeutic Compositions Comprising It
  • Method Of Determining Virus Removal From A Sample Containing A Target Protein Using Activated Carbon
  • Neutralizing Prolactin Receptor Antibody Mat3 And Its Therapeutic Use
  • Compositions And Methods For Growth Factor Modulation
  • Chimeric Peptides Comprising Her-2 B-Cell Epitopes And Tcell Helper Epitopes
  • Antibodies Against The Rgm A Protein And Uses Thereof
  • Copd Diagnosis
  • Hmg1 Antibody For Treating Inflammatory Conditions
  • Anti-Cmet Antibody
  • Therapeutic Dll4 Binding Proteins
  • Monoclonal Antibodies Against Hmgb1
  • Bifunctional Histone Deacetylase Inhibitors
  • Detection And Quantitation Of Full-Length Thioredoxin (Trx) And Truncated Thioredoxin (Trx 80) In Complex Samples
  • Peptides And Methods Using Same For Diagnosis And Treatment Of Amyloid-Associated Disease
  • Pd-1 Antibody
  • Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
  • Antigen Binding Protein And Its Use As Addressing Product For The Treatment Of Cancer
  • Compositions For Analyzing Proteins
  • Modified Polynucleotides Encoding Basic Helix-Loop-Helix Family Member E41
  • Compositions And Methods For The Therapy And Diagnosis Of Influenza
  • Monoclonal Antibodies Reactive With Endotoxin Core
  • Anti-Cmet Antibody
  • Pharmaceutical Preparation Containing Protein C And A Thrombolytically Active Substance
  • Bone Mineralization Proteins, Dna, Vectors, Expression Systems
  • Peptides Derived From A Retrovirus Of The Hiv Group And Their Use
  • Antibody-Sn-38 Immunoconjugates With A Cl2a Linker
  • Methods And Systems For Using Rfid In Biological Field
  • Anti Human Interleukin-1 Receptor Accessory Protein (Il1 Rap) Antibodies And Uses Thereof
  • Antibody-Active Agent Conjugates And Methods Of Use
  • Molecules, Compositions, Methods And Kits For Applications Associated With Flaviviruses
  • Method For Detection Of L523s Expression In Biological Samples
  • Pyrrolobenzodiazepines And Conjugates Thereof
  • Stable Antibody Containing Compositions
  • Encapsulation Of Pancreatic Cells Derived From Human Pluripotent Stem Cells
  • Multicomponent Immunogenic Composition For The Prevention Of Beta-Hemolytic Streptococcal (Bhs) Disease
  • Anti-Il-23 Heterodimer Specific Antibodies
  • Recombinant Antibodies Against Hepatitis C Virus And Methods Of Obtaining And Using Same
  • Ror1-Binding Molecules, And Methods Of Use Thereof
  • Compositions Capable Of Specifically Binding Particular Human Antigen Presenting Molecule/Pathogen-Derived Antigen Complexes And Uses Thereof
  • Antibody Molecules Having Specificity For Human Ox40
  • Methods And Compositions For Assessing Responsiveness Of B-Cell Lymphoma To Treatment With Anti-Cd40 Antibodies
  • Antibodies To Receptor For Advanced Glycation End Products (Rage) And Uses Thereof
  • Immunoassay Of Analytes In Samples Containing Endogenous Anti-Analyte Antibodies
  • Histone Deacetylases, And Uses Related Thereto
  • Soluble Glycosaminoglycanases And Methods Of Preparing And Using Soluble Glycosaminoglycanases
  • Bgl3 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Peptides Derived From A Retrovirus Of The Hiv Group And Their Use
  • Mass Spectrometric Methods And Products
  • Β-Trcp1, Β-Trcp2 And Rsk1 Or Rsk2 Inhibitors And Methods For Sensitizing Target Cells To Apoptosis
  • Modified Polynucleotides For The Production Of Proteins
  • Method Of Treating Cancer By Administering Egfr And Egfr/Igfir Binding Molecules
  • Genetic Markers Associated With Risk Of Diabetes Mellitus
  • Chondrosarcoma Associated Genes
  • Hepatocyte Growth Factor Receptor Antagonists And Uses Thereof
  • Hybrid Immunoglobulin-Thrombolytic Enzyme Molecules Which Specifically Bind A Thrombus, And Methods Of Their Production And Use
  • Nucleic Acid Preparation Methods
  • Immobilization Of Biologically Active Substances With Carrier Bond Antibody
  • Mutations In Ion Channels
  • Hybridomas And Monoclonal Paratopic Molecules To Apolipoprotein A-I
  • Human Inkt Cell Activation Using Glycolipids
  • Methods For Treating Colon Cancer And Inflammation Associated With Overexpression Of Human Signal Peptide-Containing Proteins
  • 2,5-Diketo-L-Gluconic Acid Reductases And Methods Of Use
  • Methods And Kits For Diagnosing Tumorigenicity And Determining Resistance To The Antineoplastic Effects Of Antiestrogen Therapy
  • Glycoprotein
  • Gitr Antigen Binding Proteins And Methods Of Use Thereof
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • High Throughput Generation And Affinity Maturation Of Humanized Antibody
  • Anti-Human Il-21 Antibodies
  • Tet2 As A Diagnostic And Pronostic Marker In Hematopoietic Neoplasms
  • Biomarkers For Determining Breast Cancer Bone Metastasis
  • Methods For The Prognosis Of Breast Cancer
  • Notch1 Receptor Antibodies And Methods Of Treatment
  • Polynucleotides Encoding Notch Receptor Antibodies
  • Methods And Compositions For Inhibiting The Growth Of Hematopoietic Malignant Cells
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Antigen Binding Protein And Its Use As Addressing Product For The Treatment Of Cancer
  • Costimulatory B7-H1 In Renal Cell Carcinoma Patients: Indicator Of Tumor Aggressiveness And Potential Therapeutic Target
  • Modified Polynucleotides For The Production Of Oncology-Related Proteins And Peptides
  • Dock-And-Lock (Dnl) Complexes For Therapeutic And Diagnostic Use
  • Methods For Treating Conditions Associated With Masp-2 Dependent Complement Activation
  • Antigen Binding Proteins
  • Locating Intravascular Images
  • Antibodies Directed To Bacillus Anthracis Protective Antigen
  • Antibodies Directed Against Signal Peptides, Methods And Uses Thereof
  • Methods Of Generating Cells Exhibiting Phenotypic Plasticity
  • Antibody Specific For Clec14a And Uses Thereof
  • Intravascular Forward Imaging Device
  • Nucleic Acids Encoding Chimeric Flavivirus Immunogens Comprising The Japanese Encephalitis Virus (Jev) Prm Signal Sequence
  • Cellular Permissivity Factor For Viruses, And Uses Thereof
  • Vaccinia Virus For Diagnosis And Therapy Of Tumors
  • Polypeptide
  • Bgl6 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Fusion Constructs And Use Of Same To Produce Antibodies With Increased Fc Receptor Binding Affinity And Effector Function
  • Anti-Cd74 Immunoconjugates And Methods Of Use
  • Genetic Variants On Chr 5p12 And 10q26 As Markers For Use In Breast Cancer Risk Assessment, Diagnosis, Prognosis And Treatment
  • Multicomponent Immunogenic Composition For The Prevention Of Beta-Hemolytic Streptococcal (Bhs) Disease
  • Methods For Identifying And Isolating Cells Expressing A Polypeptide
  • Anti-C-Met Antibody
  • Vaccinia Virus For Diagnosis And Therapy Of Tumors
  • Inhibition And Treatment Of Prostate Cancer Metastasis
  • Anti-Cmet Antibody
  • Bacterial Virulence Factors And Uses Thereof
  • A Method For The Diagnosis Or Monitoring Of Cancer In A Patient
  • Cellular Permissivity Factor For Viruses, And Uses Thereof
  • Cd3-Binding Molecules Capable Of Binding To Human And Non-Human Cd3
  • Processable Single Chain Molecules And Polypeptides Made Using Same
  • Guidewire Artifact Removal In Images
  • Costimulatory B7-H1 In Renal Cell Carcinoma Patients: Indicator Of Tumor Aggressiveness And Potential Therapeutic Target
  • Dock-And-Lock (Dnl) Complexes For Therapeutic And Diagnostic Use
  • Modified Polynucleotides For The Production Of Oncology-Related Proteins And Peptides
  • Antigen Binding Proteins
  • Methods Of Generating Cells Exhibiting Phenotypic Plasticity
  • Antibody Specific For Clec14a And Uses Thereof
  • Idiotypic Antibodies And Uses Thereof
  • Activin Neutralisers And Uses Thereof For Treatment Of Diseases Associated With Aberrant "Host Defence Response" Activation
  • Tcr-V-Beta Related Peptides For Treatment And Diagnosis Of Autoimmune Disease
  • Lafora's Disease Gene
  • Modified Polynucleotides For The Production Of G-Csf
  • Nucleic Acids Encoding Chimeric Polypeptides For Library Screening
  • Combination Therapy For Treating Disease
  • Combination Of Angiopoietin-2 Antagonist And Of Vegf-A, Kdr And/Or Fltl Antagonist For Treating Cancer
  • Plant Centromere Compositions
  • Nucleic Acid Encoding Scn1a Variant
  • Hiv-1 Neutralizing Antibodies And Uses Thereof
  • Biomarkers For Wound Healing
  • High Affinity Nucleic Acid Ligands Of Complement System Proteins
  • Uncoupled Collagen Synthesis And Degradation Assays
  • Lipoprotein Associated Phospholipase A2, Inhibitors Thereof And Use Of The Same In Diagnosis And Therapy
  • Glypican-3 (Gpc3)-Derived Tumor Rejection Antigenic Peptides Useful For Hla-A2-Positive Patients And Pharmaceutical Comprising The Same
  • Glycoprotein Vi And Uses Thereof
  • Method To Identify A Patient With An Increased Likelihood Of Responding To An Anti-Cancer Therapy
  • Antibodies With Immune Effector Activity And That Internalize In Folate Receptor Alpha-Positive Cells
  • Anti-Igf-Ir Antibodies And Uses Thereof
  • Dna Methylation Markers Associated With The Cpg Island Methylator Phenotype (Cimp) In Human Colorectal Cancer
  • Secreted Streptococcus Pneumoniae Proteins
  • Immunogenic Compositions For The Prevention And Treatment Of Meningococcal Disease
  • Diagnosis Of Liver Pathology Through Assesment Of Protein Glycosylation
  • Nucleic Acids Encoding Chimeric Flavivirus Immunogens Comprising The Japanese Encephalitis Virus (Jev) Prm Signal Sequence
  • Borrelia Antigens
  • Anti-Cd74 Immunoconjugates And Methods Of Use
  • Antibodies That Bind To Psca Proteins For Diagnosis Of Cancer
  • Communications Network System And Methods For Using Same
  • Alpha-Fetoprotein Immu31 Antibodies And Fusion Proteins And Methods Of Use Thereof
  • Composition For Treating A Pathology Associated With Msrv/Herv-W
  • 4-1bb Binding Molecules
  • Pyrrolobenzodiazepines And Conjugates Thereof
  • Bcr-Abl1 Splice Variants And Uses Thereof
  • Human Anti-B7rp1 Neutralizing Antibodies
  • Staphylococcus Aureus Materials And Methods
  • Monoclonal Antibody To Human Cytotoxic And Suppressor T Cells, And Method Of Preparing It
  • Monoclonal Antibody To Human Cytotoxic And Suppressor T Cells, And Method Of Preparing It
  • Method And Nucleic Acids For The Analysis Of Colorectal Cell Proliferative Disorders
  • Antibody Composition With Altered Fab Sialylation
  • Soluble Glycosaminoglycanases And Methods Of Preparing And Using Soluble Glycosaminoglycanases
  • Monoclonal Antibodies Specific For Human Basal Cell And Malignant Squamous Cell Protein, Hybridomas Therefor, Malignancy Test Methods And Diagnostic Kits
  • Monoclonal Antibodies Specific For Human Basal Cell And Malignant Squamous Cell Protein, Hybridomas Therefor, Malignancy Test Methods And Diagnostic Kits
  • Monoclonal Antibodies Against Tumor-Associated Antigens, A Process For The Preparation Thereof And The Use Thereof
  • Therapeutic Epitopes And Uses Thereof
  • Variants Of Cellobiohydrolases
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Antibody Reactive To Hamster Immunoglobulins
  • A Monoclonal Antibody Specific For Myosin In The Brain
  • Anti-Folate Receptor Alpha (Fra) Antibody-Drug Conjugates And Methods Of Using Thereof
  • Antibody Producing Non-Human Mammals
  • Il-6 Antagonists And Uses Thereof
  • Method For Determining The Β-Subunit Of Human Prolyl Hydroxylase By Radioimmunoassay To Detect Hepatic Disease
  • Cell Lines For Use In The Preparation Of Hybridoma Cells
  • Monoclonal Antibodies To Progastrin
  • Novel Cancer Marker And Utilization Thereof
  • Human Anti-B7rp1 Neutralizing Antibodies
  • Monoclonal Antibody That Binds Human Notch2 And Notch3
  • Anti-Ngf Antibodies And Methods Using Same
  • Hybridoma Cell Lines And Monoclonal Antibodies Recognizing Prox1
  • Antibody Therapy Of Tumors
  • Diagnostic Antibody Assay
  • Isolation And Characterization Of The Csa Operon (Etec-Cs4 Pili) And Methods Of Using Same
  • Apaf-1 An Activator Of Caspase-3
  • O-Fucosyltransferase
  • Anti-Amyloid Antibodies And Uses Thereof
  • Combination Therapy With Anti-Cd74 Antibodies Provides Enhanced Toxicity To Malignancies, Autoimmune Disease And Other Diseases
  • Method For Enzymatic Production Of Decarboxylated Polyketides And Fatty Acids
  • Enzymes
  • Soluble Hyaluronidase Glycoprotein (Shasegp), Process For Preparing The Same, Uses And Pharmaceutical Compositions Comprising Thereof
  • Isolation And Propagation Of A Human Herpesvirus Derived From Aids-Associated Kaposi's Sarcoma Cells
  • Terminally Modified Rna
  • Low Cost, Portable Sensor For Molecular Assays
  • Peptides Derived From Cytotoxicity Receptor Natural Killer Protein 44 Nkp44
  • Stimuli-Responsive Polymer Diagnostic Assay Comprising Magnetic Nanoparticles And Capture Conjugates
  • Cancer Diagnosis And Imaging
  • Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
  • Methods And Reagents For Detecting Bioactive Lipids
  • Therapeutic Dll4 Binding Proteins
  • Uses Of Monoclonial Antibody 8h9
  • Monoclonal Antibodies To Progastrin
  • Novel Cancer Marker And Utilization Thereof
  • Haptens Of Quetiapine
  • Secreted Streptococcus Pneumoniae Proteins
  • Immunogenic Compositions For The Prevention And Treatment Of Meningococcal Disease
  • Method To Identify A Patient With An Increased Likelihood Of Responding To An Anti-Cancer Therapy
  • Lipoprotein Associated Phospholipase A2, Inhibitors Thereof And Use Of The Same In Diagnosis And Therapy
  • Egvi Endoglucanase And Nucleic Acids Encoding The Same
  • Methods For Detecting Oncofetal Fibronectin
  • Bgl3 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • High Affinity Nucleic Acid Ligands Of Complement System Proteins
  • Uncoupled Collagen Synthesis And Degradation Assays
  • Polypeptide Having Heparanase Activity
  • Neisserial Antigens
  • Methods And Systems For Determining The Biological Function Of Cell Constituents Using Response Profiles
  • Methods Of Treating Viral Disorders
  • Regulatory Segments Of The Human Gene For Telomerase Reverse Transcriptase
  • Polynucleotide And Protein Involved In Synaptogenesis, Variants Thereof, And Their Therapeutic And Diagnostic Uses
  • Neutralizing Monoclonal Antibodies Against The Nogo-66 Receptor (Ngr)
  • Β-Glucosidase 5 (Bgl5) Compositions
  • Methods And Compositions For Modulating T Helper (Th) Cell Development And Function
  • Relaxin-3 Chimeric Polypeptides And Their Preparation And Use
  • Differentiation Of Multi-Lineage Progenitor Cells To Hepatocytes
  • Canine Transient Receptor Potential V2 (Ctrpv2) And Methods Of Screening For Trpv2 Channel Modulators
  • Use Of Dg177 Secreted Protein Products For Preventing And Treating Pancreatic Diseases And/Or Obesity And/Or Metabolic Syndrome
  • Diagnostic And Therapeutic Epitope, And Transgenic Plant
  • Nucleic Acids Coding For Adhesion Factors Of Group B Streptococcus, Adhesion Factors Of Group B Streptococcus And Futher Uses Thereof
  • Biomarkers For Wound Healing
  • Glypican-3 (Gpc3)-Derived Tumor Rejection Antigenic Peptides Useful For Hla-A2-Positive Patients And Pharmaceutical Comprising The Same
  • Fragments Of Antibodies To Epidermal Growth Factor Receptor And Methods Of Their Use
  • Kid3 And Kid3 Antibodies That Bind Thereto
  • Nfia In Glial Fate Determination, Glioma Therapy And Astrocytoma Treatment
  • Plant Centromere Compositions
  • Nucleic Acid Encoding Scn1a Variant
  • Hiv-1 Neutralizing Antibodies And Uses Thereof
  • Communications Network System And Methods For Using Same
  • Alpha-Fetoprotein Immu31 Antibodies And Fusion Proteins And Methods Of Use Thereof
  • Composition For Treating A Pathology Associated With Msrv/Herv-W
  • Combination Therapy For Treating Disease
  • Glycoprotein Vi And Uses Thereof
  • Antibodies With Immune Effector Activity And That Internalize In Folate Receptor Alpha-Positive Cells
  • Anti-Igf-Ir Antibodies And Uses Thereof
  • Dna Methylation Markers Associated With The Cpg Island Methylator Phenotype (Cimp) In Human Colorectal Cancer
  • Borrelia Antigens
  • Anti-Cd74 Immunoconjugates And Methods Of Use
  • Diagnosis Of Liver Pathology Through Assesment Of Protein Glycosylation
  • Antibodies That Bind To Psca Proteins For Diagnosis Of Cancer
  • Methods Of Purifying Fc Region Containing Proteins
  • Tumor-Associated Marker
  • Protein Similar To Neuroendocrine-Specific Protein, And Encoding Cdna
  • Sequences From Piscirickettsia Salmonis
  • F11 Receptor (F11r) Antagonists As Therapeutic Agents
  • Modulation Of Drug Resistance Via Ubiquitin Carboxy-Terminal Hydrolase
  • Identification Of Two Novel Mutant Alleles Of Human Thiopurine S-Methyltransferase, And Diagnostic Uses Thereof
  • Fluorescence Immunoassays Using Fluorescent Dyes Free Of Aggregation And Serum Binding
  • Method To Determine Metastatic Potential Of Tumor Cells
  • Hepatocyte Growth Factor Receptor Antagonists And Uses Thereof
  • Quinidine Conjugates And Their Use In Immunoassays
  • Uses Of Wnt Polypeptides
  • O-Fucosyltransferase
  • Targeted Immunostimulation With Bispecific Reagents
  • Staphylococcus Aureus Materials And Methods
  • Human Anti-B7rp1 Neutralizing Antibodies
  • Therapeutic Epitopes And Uses Thereof
  • Flt4, A Receptor Tyrosine Kinase
  • Use Of Pairs Of Leucine Zipper Peptides In Immunoassay Methods
  • Method Of Treating Colorectal Carcinoma Lesion And Composition For Use Therein
  • Isolated Dna Encoding Human Gp2
  • Metal Ion-Ligand Coordination Complexes, Antibodies Directed Thereto, And Assays Using Such Antibodies
  • Metal Ion-Ligand Coordination Complexes, Antibodies Directed Thereto, And Assays Using Such Antibodies
  • Anti-Human Pulmonary Adenocarcinoma Specific Monoclonal Antibody
  • Β3 Integrin Subunit Specific Polypeptides, Cdnas Which Encode These Polypeptides And Method Of Producing These Polypeptides
  • Encapsulation Of Pancreatic Cells Derived From Human Pluripotent Stem Cells
  • Compositions Produced Using Enteric Pathogens And Methods Of Use
  • Il-6 Antagonists And Uses Thereof
  • Pyrrolobenzodiazepine-Antibody Conjugates
  • Scaffold Proteins Derived From Plant Cystatins
  • Chimeric Ospa Genes, Proteins And Methods Of Use Thereof
  • Modified Polynucleotides For The Production Of Cosmetic Proteins And Peptides
  • Processable Single Chain Molecules And Polypeptides Made Using Same
  • Guidewire Artifact Removal In Images
  • Protease-Activated Receptor 3 And Uses Thereof
  • 3′-Phosphoadenosine -5′-Phosphosulfate Synthetase 2 (Papss2) Sequence Variants
  • 88kda Tumorigenic Growth Factor And Antagonists
  • Non-Maltogenic Exoamylases And Their Use In Retarding Retrogradation Of Starch
  • Polymer Brushes For Immobilizing Molecules To A Surface Or Substrate Having Improved Stability
  • Chimeric Retroviral Gag Genes And Screening Assays
  • Antibodies That Bind To Cancer-Associated Antigen Cd46 And Methods Of Use Thereof
  • Bone Mineralization Proteins, Dna, Vectors, Expression Systems
  • Nucleic Acid Vaccines For Prevention Of Flavivirus Infection
  • Optical Coherence Tomography System That Is Reconfigurable Between Different Imaging Modes
  • Systems And Methods For Amplifying Light
  • Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
  • Antibodies Specific For Tgf-Β And Methods Of Treatment Thereof
  • Immunizing Compositions And Methods Of Use
  • S. Pneumoniae Antigens
  • Combination Therapy For The Treatment Of Tumors
  • 3′-Phosphoadenosine -5′-Phosphosulfate Synthetase 2 (Papss2) Sequence Variants
  • Chimeric Retroviral Gag Genes And Screening Assays
  • Antibodies That Bind To Cancer-Associated Antigen Cd46 And Methods Of Use Thereof
  • Preferred Segments Of Neural Thread Protein
  • Methods For Treating Post-Surgical Pain By Administering An Anti-Nerve Growth Factor Antagonist
  • Genes And Proteins Involved In The Biosynthesis Of Lipopeptides
  • Nucleic Acid Vaccines For Prevention Of Flavivirus Infection
  • Method Of Detecting Native Probnp
  • Purified And Recombinant Antigenic Protein Associated With Abdominal Aortic Aneurysm (Aaa) Disease, And Diagnostic And Therapeutic Use Thereof
  • Xylanase From Trichoderma Reesei , Method For Production Thereof, And Methods Employing This Enzyme
  • Nuclear Matrix Protein Fluid Assay
  • Complex Of Lipo-Viro-Particles, Method Of Preparation And Applications
  • Assays Involving An Il-1 Receptor Antagonist
  • Method For Screening For Drug Candidates For Modulating Transcription Factor Activity
  • Method, Array And Kit For Detecting Activated Transcription Factors By Hybridization Array
  • Antibodies To Cytokinins Having A Glycosylated Isoprenoid Side Chain And Immunoassay Methods
  • Purification Of Plasminogen Activator Inhibitor 2 By Immunoaffinity Chromatography
  • Triasulfurone Compounds
  • Method Of Preparing Activated Protein C
  • Monoclonal Antibodies And Methods For Fungal Pathogen Detection
  • Monoclonal Antibodies To Bluetongue Virus Antigen
  • Monoclonal Antibodies To Epizootic Hemorrhagic Disease Virus Antigen
  • Ankyrin G And Modulators Thereof For The Treatment Of Neurodegenerative Disorders
  • Methods To Increase Or Decrease Bone Density
  • Protein Similar To Neuroendrocrine-Specific Protein, And Encoding Cdna
  • Thyronamine Derivatives And Analogs And Methods Of Use Thereof
  • Bgl3 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Immunoliposomes For Transmittal Of Activating Signals To Cells
  • Primitive Cell Colony Stimulating Factors Vectors, Antibodies, And Methods Of Use
  • Synthesis Of Human Procollagens And Collagens In Recombinant Dna Systems
  • Monoclonal Antibody
  • Mutations Associated With Iron Disorders
  • Nucleic Acid Fragment Encoding An Nrps For The Biosynthesis Of Anthramycin
  • Bgl4 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Neisseria Meningitidis Compositions And Methods Thereof
  • Method For Reduction Of Interferences In Immunoassays
  • Soluble Hyaluronidase Glycoprotein (Shasegp), Process For Preparing The Same, Uses And Pharmaceutical Compositions Comprising Thereof
  • Induced Activation In Dendritic Cells
  • Stem Cell Factor Inhibitor
  • Compositions And Methods For Diagnosing And Treating Cancer And Neurodegenerative Diseases Related To Beclin-1
  • Surface Protein (Hbsag) Variant Of The Hepatitis B Virus
  • Antibodies For Depletion Of Icos-Positive Cells In Vivo
  • Application Of Mrna For Use As A Therapeutic Against Tumour Diseases
  • Antibody Against Amyloid Precursor Protein Signal Peptide
  • Protein Formulation
  • Hla-Restricted, Peptide-Specific Antigen Binding Proteins
  • Method For Selecting A Single Cell Expressing A Heterogeneous Combination Of Antibodies
  • Modified Polynucleotides Encoding Siah E3 Ubiquitin Protein Ligase 1
  • Antibody-Based Therapeutics With Enhanced Adcc Activity
  • Compounds Inhibiting Cd95 Signaling For The Treatment Of Pancreatic Cancer
  • Genetic Variants Contributing To Risk Of Prostate Cancer
  • Genetic Markers For Risk Management Of Atrial Fibrillation And Stroke
  • Multiplex Protein Fractionation
  • Effective New Drug Target For The Treatment Of Tuberculosis
  • Compositions And Methods For Treating And Diagnosing Irritable Bowel Syndrome
  • Optical Coherence Tomography System That Is Reconfigurable Between Different Imaging Modes
  • Immunizing Compositions And Methods Of Use
  • S. Pneumoniae Antigens
  • Combination Therapy For The Treatment Of Tumors
  • Systems And Methods For Amplifying Light
  • Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
  • Human Adenylsuccinate Synthetase And Polynucleotides Encoding The Same
  • Prostaglandin D Synthase-Specific Monoclonal Antibody
  • Polymer Brushes For Immobilizing Molecules To A Surface Or Substrate Having Improved Stability
  • Antibodies Specific For Tgf-Β And Methods Of Treatment Thereof
  • Antibodies For Prevention And Treatment Of Diseases Caused By Clostridium Difficile
  • Alkynyl Sugar Analogs For Labeling And Visualization Of Glycoconjugates In Cells
  • Bispecific Anti-Vegf/Anti-Ang-2 Antibodies And Their Use In The Treatment Of Ocular Vascular Diseases
  • Bnp(1-32) Epitope And Antibodies Directed Against Said Epitope
  • Purified Antibodies Which Specifically Bind Human Abnormal Prothrombin
  • Pharmaceutical Preparation Containing Protein C And A Thrombolytically Active Substance
  • Dlin-Kc2-Dma Lipid Nanoparticle Delivery Of Modified Polynucleotides
  • Her-3 Antibodies And Methods Of Use
  • Methods And Compositions Related To Mutant Kunitz Domain I Of Tfpi-2
  • Inhibition And Treatment Of Prostate Cancer Metastasis
  • Anti-Mesothelin Antibodies
  • Function Modifying Nav 1.7 Antibodies
  • Catheter For In Vivo Imaging
  • Application Of Mrna For Use As A Therapeutic Against Tumour Diseases
  • Anti-Human Igg1 Antibody
  • Antibody Constructs For Cdh19 And Cd3
  • Multiple Signaling Pathways Induced By Hexavalent, Monospecific And Bispecific Antibodies For Enhanced Toxicity To B-Cell Lymphomas And Other Diseases
  • Modified Polynucleotides For The Production Of Secreted Proteins
  • Diagnostic Test For Vitamin B12
  • Method For Treating Hypophosphatemic Bone Diseases Using Fgf-23 Antibody
  • Immune Regulation Based On The Targeting Of Early Activation Molecules
  • Uses Of Monoclonal Antibody 8h9
  • Antibodies Which Bind To Signal Peptide-Containing Molecules
  • Dengue Virus Neutralizing Antibodies And Use Thereof
  • Peptides And Methods Using Same For Diagnosis And Treatment Of Amyloid-Associated Disease
  • Methods For Mediating Fibrotic Response
  • Controlled Platelet Activation To Monitor Therapy Of Adp Antagonists
  • Antibodies To Human Β-Adrenergic Receptor Kinase
  • Method For The Early Diagnosis Of Malign Tumours In Mammals And Humans
  • Method For The Early Diagnosis Of Malign Tumours In Mammals And Humans
  • Antibodies With Immune Effector Activity And That Internalize In Endosialin-Positive Cells
  • Cc-Chemokine Binding Tick Proteins
  • Circovirus Sequences Associated With Piglet Weight Loss Disease (Pwd)
  • Tuberculosis Vaccines Comprising Antigens Expressed During The Latent Infection Phase
  • Nucleic Acid Molecules Containing Recombination Sites And Methods Of Using The Same
  • Borrelia Antigens
  • Centromere Sequences And Minichromosomes
  • Ionic Strength-Mediated Ph Gradient Ion Exchange Chromatography
  • Non-Maltogenic Exoamylases And Their Use In Retarding Retrogradation Of Starch
  • Methods And Compositions Relating To Cd39-Like Polypeptides And Nucleic Acids
  • Specific Monoclonal Antibody Against Terbinafine
  • Human Medical Treatment By Aerosol Inhalation Of Immunoglobulin A
  • Antigen Pipa And Antibodies That Bind Thereto
  • Fwd, Pp2c1, Adk3, Cg3860, Cdk4, Cg7134, Eip75b Involved In The Regulation Of Energy Homeostasis
  • Fragments And Variants Of Staphylococcus Aureus Dnag Primase, And Uses Thereof
  • Non-Affinity Purification Of Proteins
  • Process For Making T Cell Hybridomas
  • Monoclonal Antibody Directed Against Cd166 And Method For Production Thereof
  • Detection Method Of Gynecologic Cancer
  • Beta Secretase Genes
  • Angiogenesis Inhibiting Molecules, Their Selection, Production And Their Use In The Treatment Of Cancer
  • Methods Of Inducing Flavivirus Immune Responses Through The Administration Of Recombinant Flaviviruses Comprising An Engineered Japanese Encephalitis Virus Signal Sequence
  • Compositions And Methods For Restoring Sensitivity Of Tumor Cells To Antitumor Therapy And Inducing Apoptosis
  • Modulation Of T Cell Differentiation For The Treatment Of T Helper Cell Mediated Diseases
  • Humanized Antibody Specific For Tumor Necrosis Factor-Alpha
  • Biomarkers Of Liver Injury
  • Immunoassay Of Antigens
  • Hybrid Cell Line For Producing Monoclonal Antibody To Human Thymocyte Antigen, Antibody, Method Of Preparation Of This Antibody, Diagnostic And Therapeutic Uses And Pharmaceutical Compositions Comprising This Antibody
  • Hybrid Cell Line For Producing Monoclonal Antibody To Human Thymocyte Antigen, Antibody, Method Of Preparation Of This Antibody, Diagnostic And Therapeutic Uses And Pharmaceutical Compositions Comprising This Antibody
  • Targeted Therapeutics Based On Engineered Proteins That Bind Egfr
  • Haptens Of Paliperidone
  • Inhibitors Of Type 2 Vascular Endothelial Growth Factor Receptors
  • Circovirus Sequences Associated With Piglet Weight Loss Disease (Pwd)
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Haptens Of Quetiapine
  • Methods And Reagents For Detecting Bioactive Lipids
  • Anti-Angiogenic Therapy
  • Compositions And Methods For The Treatment Of Tumor Of Hematopoietic Origin
  • H. Pylori Lipopolysaccharide Outer Core Epitope
  • Treatment Of Protein Degradation Disorders
  • Therapeutic Dll4 Binding Proteins
  • Uses Of Monoclonial Antibody 8h9
  • Glypican-3 (Gpc3)-Derived Tumor Rejection Antigenic Peptides Useful For Hla-A2-Positive Patients And Pharmaceutical Comprising The Same
  • Method To Identify A Patient With An Increased Likelihood Of Responding To An Anti-Cancer Therapy
  • Chimeric T Cell Receptor Comprising Carbonic Anhydrase Ix (G250) Antibody
  • Modified Polynucleotides Encoding Hepatitis A Virus Cellular Receptor 2
  • Methods For The Treatment Of Cancer And Inflammatory Diseases Using Cereblon As A Predictor
  • Therapeutic Composition For Treatment Of Glioblastoma
  • Method For Detecting Transcription Factor-Protein Interactions
  • In Vivo Production Of Proteins
  • Process For Decreasing Verbascose In A Plant By Expression Of A Chloroplast-Targeted Fimd Protein
  • Method Of Modulating Inflammatory Response By Downregulation Of Activin
  • Flavivirus Neutralizing Antibodies And Methods Of Use Thereof
  • Haptens Of Aripiprazole
  • Antibodies Reactive With B7-H3, Immunologically Active Fragments Thereof And Uses Thereof
  • Identification Of Antigen Or Ligand-Specific Binding Proteins
  • Means And Methods For Treating And/Or Preventing Natural Ahr Ligand-Dependent Cancer
  • Generation Of Binding Molecules
  • Method And Apparatus To Identify Vulnerable Plaques With Thermal Wave Imaging Of Heated Nanoparticles
  • Zanamivir Phosphonate Congeners With Anti-Influenza Activity And Determining Oseltamivir Susceptibility Of Influenza Viruses
  • Antibody-Sn-38 Immunoconjugates With A Cl2a Linker
  • Methods For Detecting Expression Levels Of Human Signal Peptide-Containing Proteins (Hspp)
  • Monoclonal-Antibody-Producing Hybrid Cell Line, Antibody And Method Of Preparing It, Therapeutic Composition Containing It And Its Diagnostic And Therapeutic Uses
  • Hybrid Cell Line For Producing Monoclonal Antibody To A Human Monocyte Antigen, Antibody, And Methods
  • Hybrid Cell Line For Producing Monoclonal Antibody To A Human T Cell Antigen, Antibody, And Methods
  • Bispecific Molecules That Are Immunoreactive With Immune Effector Cells That Express An Activating Receptor And An Antigen Expressed By A Cell Infected By A Virus And Uses Thereof
  • A Purified 80 Kda Protein Implicated In Abdominal Aortic Aneurysms, Antibodies Directed Thereto, And Uses Thereof
  • Secreted Proteins
  • Stem Cell Factor Inhibitor
  • Targeting Metabolic Enzymes In Human Cancer
  • 5-Hydroxymethylcytosine In Human Cancer
  • Methods And Compositions For Generating An Immune Response By Inducing Cd40 And Pattern Recognition Receptor Adapters
  • Β-Amyloid Peptide-Binding Proteins And Polynucleotides Encoding The Same
  • Mutations In Human Mlh1 And Human Msh2 Genes Useful In Diagnosing Colorectal Cancer
  • Serum Immunoregulatory Polypeptides And Uses Therefor
  • Purified Lymphadenopathy And Acquired Immune Deficiency Syndrome Virus And Envelope Antigens Of This Virus, Method For Obtaining This Virus And These Envelope Antigens Of This Virus, Uses Of This Virus Or Of These Antigens In The Preparation Of Immunogenic Compositions Or For The Diagnosis Of The Abovementioned Pathologies
  • Antibodies To Angiogenin: Immunotherapeutic Agents.
  • Combining Anti-Hla-Dr Or Anti-Trop-2 Antibodies With Microtubule Inhibitors, Parp Inhibitors, Bruton Kinase Inhibitors Or Phosphoinositide 3-Kinase Inhibitors Significantly Improves Therapeutic Outcome In Cancer
  • Anti-Tissue Factor Antibodies And Compositions
  • Optical-Electrical Rotary Joint And Methods Of Use
  • Crosslinking Of Cd22 By Epratuzumab Triggers Bcr Signaling And Caspase-Dependent Apoptosis In Hematopoietic Cancer Cells
  • Methods For Identifying And Isolating Cells Expressing A Polypeptide
  • Methods And Compositions For Synthesis Of Nucleic Acid Molecules Using Multiplerecognition Sites
  • Polynucleotides Encoding Notch1 Receptor Antibodies
  • Hepatocyte Lineage Cells
  • Immunizing Compositions And Methods Of Use
  • Kid3 And Kid3 Antibodies That Bind Thereto
  • Bgl3 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Methods For Anti-Fibrinolytic Treatment Using Mmp-10 Neutralizing Antibody
  • Comb Polymers
  • Modified Amylases, Nucleic Acids Encoding Those Amylases And Uses Thereof
  • Antibodies To Carcinoembryonic Antigen-Related Cell Adhesion Molecule (Ceacam)
  • Human Tumor Necrosis Factor Delta And Epsilon
  • Modified Amylases From Pseudomonas Species, Methods Of Making And Uses Thereof
  • Autoantibody Enhanced Immunoassays And Kits
  • Plants Modified With Mini-Chromosomes
  • Kid31 And Antibodies That Bind Thereto
  • Anti-Cd74 Immunoconjugates And Methods Of Use
  • Aptamer Therapeutics Useful In The Treatment Of Complement-Related Disorders
  • Methods Of Treating Diabetes And Compositions Capable Of Same
  • Egvii Endoglucanase And Nucleic Acids Encoding The Same
  • Inositol-Phosphate Derivatives And Method Of Detecting Inositol-1-Phosphate
  • Autoantibody Enhanced Immunoassays And Kits
  • Cancerous Disease Modifying Antibodies
  • Soluble Glycosaminoglycanases And Methods Of Preparing And Using Soluble Glycosaminoglycanases
  • Composition For Treating Pathology Associated With Msrv/Herv-W
  • Methods Of Preparing And Using Single Chain Anti-Tumor Antibodies
  • Methods For Treating Pain By Administering A Nerve Growth Factor Antagonist And An Nsaid
  • Methods To Increase Or Decrease Bone Density
  • Anti-Apoptotically Active Apatamers
  • Chimeric Antibody Against Tumor Associated Antigens And Its Use In Diagnosing Tumors
  • Labeled Peptides, Proteins And Antibodies And Processes And Intermediates Useful For Their Preparation
  • Methods For Producing Members Of Specific Binding Pairs
  • Compositions And Methods In Cancer Associated With Altered Expression Of Kcnj9
  • Dengue Virus Neutralizing Antibodies And Uses Thereof
  • Uses Of Monoclonal Antibody 8h9
  • Uses Of Monoclonal Antibody 8h9
  • Engineered Anti-Cd20 Antibody Fragments For In Vivo Targeting And Therapeutics
  • Methods For Treating Conditions Associated With The Accumulation Of Excess Extracellular Matrix
  • Junctional Adhesion Molecule-C (Jam-C) Binding Compounds And Methods Of Their Use
  • Feeding Formula Appliance
  • Methods And Nucleic Acids For Analysis Of Cellular Proliferative Disorders
  • Circovirus Sequences Associated With Piglet Weight Loss Disease (Pwd)
  • Egvii Endoglucanase And Nucleic Acids Encoding The Same
  • Autoantibody Enhanced Immunoassays And Kits
  • Kid31 And Antibodies That Bind Thereto
  • Met Fab And Scfv Fragments
  • Antibodies Which Bind Selectively To Hair Of Animals And An Antibody Based Drug Delivery System For Animals
  • Methods Of Treating Diabetes And Compositions Capable Of Same
  • Nucleic Acid Molecules Encoding Transmembrane Serine Proteases, The Encoded Proteins And Methods Based Thereon
  • Soluble Glycosaminoglycanases And Methods Of Preparing And Using Soluble Glycosaminoglycanases
  • Autocrine Growth Factor Receptor Antibodies And Methods
  • Cancerous Disease Modifying Antibodies
  • Aptamer Therapeutics Useful In The Treatment Of Complement-Related Disorders
  • Human Tumor Necrosis Factor Delta And Epsilon
  • Modified Amylases From Pseudomonas Species, Methods Of Making And Uses Thereof
  • Autoantibody Enhanced Immunoassays And Kits
  • Inositol-Phosphate Derivatives And Method Of Detecting Inositol-1-Phosphate
  • Antibodies Directed Against Amyloid-Beta Peptide
  • Dendritic Cell Inhibitory Proteins From Ticks
  • Novel Compounds
  • Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
  • Isolated Antibodies Against Biologically Active Leptin-Related Peptides
  • Tuberculosis Vaccines Comprising Antigens Expressed During The Latent Infection Phase
  • 5.9 Kda Peptide Immunoassay Method
  • Chromosome 13-Linked Breast Cancer Susceptibility Gene
  • Tuberculosis Vaccines Comprising Antigens Expressed During The Latent Infection Phase
  • Variant Hypocrea Jecorina Cbh1 Cellulases
  • Immunomodulation Of Inflammatory Conditions Utilizing Follistatin-Like Protein-1 And Agents That Bind Thereto
  • Novel Modulators Of Trail Signalling
  • Aegyptin And Uses Thereof
  • Cell Culture Media And Methods Of Antibody Production
  • Antibodies Reactive With B7-H3 And Uses Thereof
  • Bh3 Peptides And Methods Of Use Thereof
  • Secreted Proteins
  • Using Phage Epitopes To Profile The Immune Response
  • Modulators Of Itch Ubiquitinase Activity
  • Compositions And Methods For Dengue Virus Chimeric Constructs In Vaccines
  • Anti Hla-G Specific Antibodies
  • Circovirus Sequences Associated With Piglet Weight Loss Disease (Pwd)
  • Binding Domains Of Proteins Of The Repulsive Guidance Molecule (Rgm) Protein Family And Functional Fragments Thereof, And Their Use
  • Modified Rodent Parvovirus Capable Of Propagating And Spreading Through Human Gliomas
  • Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
  • Systems And Methods For Narrowing A Wavelength Emission Of Light
  • Toll Like Receptor (Tlr) Stimulation For Ocular Angiogenesis And Macular Degeneration
  • Artificial Cell Constructs For Cellular Manipulation
  • Modified Polynucleotides For The Production Of Proteins
  • Antibodies Against Influenza Virus And Methods Of Use Thereof
  • Aβ Conformer Selective Anti-Aβ Globulomer Monoclonal Antibodies
  • Anti-Il-4/Anti-Il-13 Bispecific Antibody Formulations
  • Human Anti-Pd-1, Pd-L1, And Pd-L2 Antibodies And Uses Therefor
  • Methods Of Treating Of Diabetes And Obesity Using Fgf21 Mutants
  • Method For The Diagnosis, Prognosis And Treatment Of Breast Cancer Metastasis
  • Cell Culture Compositions With Antioxidants And Methods For Polypeptide Production
  • Antigenic Gm-Csf Peptides And Antibodies To Gm-Csf
  • Method Of Treating Endometriosis
  • Nucleic Acids And Host Cells Expressing Antibodies Capable Of Binding To The Coagulation Factor Xia And Uses Thereof
  • Anti-Sortilin Antibodies And Methods Of Use Thereof
  • Methods For The Manufacture Of Proteolytically Processed Polypeptides
  • Epithelial Cell Specific Differentiation Marker
  • Autoantibodies Which Enhance The Rate Of A Chemical Reaction
  • Antibodies To Vpf
  • Anti-Krs Monoclonal Antibody And Use Thereof
  • Pyrrolobenzodiazepines And Conjugates Thereof
  • Pyrrolobenzodiazepine-Antibody Conjugates
  • Antibody-Sn-38 Immunoconjugates With A Cl2a Linker
  • Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
  • Methods Of Producing Two Chain Proteins In Bacteria
  • Combination Therapy With Anti-Hla-Dr Antibodies And Kinase Inhibitors In Hematopoietic Cancers
  • Monoclonal Antibody To Human T Cells, Method For Preparing It, Hybrid Cell Line Producing It, Therapeutic Composition Comprising It And Diagnostic Method Using It
  • Methods And Assays For Measuring P95 And/Or P95 Complexes In A Sample And Antibodies Specific For P95
  • Cd3-Binding Molecules Capable Of Binding To Human And Non-Human Cd3
  • Glycan Conjugates And Use Thereof
  • Compositions And Methods For Treatment And Detection Of Cancers
  • Process For The Production Of Anti-Human Protein Antibody
  • Pcv2b Divergent Vaccine Composition And Methods Of Use
  • Infectious Clone Of Human Parvovirus B19 And Methods
  • Method For Producing A Protein Of Interest In A Primate
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • 88kda Tumorigenic Growth Factor And Antagonists
  • Anti-Cd74 Immunoconjugates And Methods Of Use
  • Antibodies To Carcinoembryonic Antigen-Related Cell Adhesion Molecule (Ceacam)
  • Oncolytic Viruses And Methods For Treating Neoplastic Disorders
  • Plants Modified With Mini-Chromosomes
  • Compositions Comprising Signal Peptide-Containing Proteins
  • Class- And Isoform-Specific Hdac Inhibitors And Uses Thereof
  • Use Of Pleitrophin For Preventing And Treating Pancreatic Diseases And/Or Obesity And/Or Metabolic Syndrome
  • Soluble Gp130 Muteins With Improved Binding Activity
  • Uses Of Monoclonal Antibody 8h9
  • Filipil Compositions And Methods For Treating Cancer
  • Anti-Hemagglutinin Antibody Compositions And Methods Of Use Thereof
  • Methods And Compositions For Generating An Immune Response By Inducing Cd40 And Pattern Recognition Receptor Adapters
  • Magneto-Motive Ultrasound Detection Of Magnetic Nanoparticles
  • Use Of Anti-Cd83 Agonist Antibodies For Treating Autoimmune Diseases
  • Neisseria Meningitidis Compositions And Methods Thereof
  • Non-Hla Matched Humanized Nsg Mouse Model With Patient-Derived Xenograft
  • Novel Methods For The Stabilisation Of Immunoglobulin Constant Domains
  • Neisserial Antigens
  • Human Β-Adrenergic Receptor Kinase Polypeptide And Methods
  • Autocrine Growth Factor Receptor Antibodies And Methods
  • Method For Identifiying Nucleic Acid Molecules Associated With Angiogenesis
  • Nucleotide Sequence Encoding A Mammary Cell Growth Inhibitor
  • Porcine Leptin Protein, Nucleic Acid Sequences Coding Therefor And Uses Thereof
  • Anti-Interleukin-1 Receptor Antagonist Antibodies And Uses Thereof
  • Compositions And Methods Relating To Argininosucccinate Synthetase
  • Methods And Compositions For Gamma-Secretase Assay
  • Homeobox Gene
  • Haptens Of Aripiprazole
  • Method Of Treating Cancer By Administering A Monoclonal Antibody That Binds Human Notch2 And Notch3
  • Modified Polynucleotides Encoding Aquaporin-5
  • Modified Polynucleotides For The Production Of Proteins Associated With Blood And Lymphatic Disorders
  • Method Of Stimulating Bone Marrow Regeneration
  • Histone Deacetylase Inhibitors
  • Method For Measurement Of Hepatitis C Virus
  • Sequences From Piscirickettsia Salmonis
  • Therapeutic Dll4 Binding Proteins
  • A Novel Surface Exposed Haemophilus Influenzae Protein (Protein E; Pe)
  • Toxin Detection Method
  • Modified Polynucleotides For The Production Of Cytoplasmic And Cytoskeletal Proteins
  • Cellular Permissivity Factor For Viruses And Uses Thereof
  • Alpha-Fetoprotein Immu31 Antibodies And Fusion Proteins And Methods Of Use Thereof
  • Foxc1 Antibodies And Methods Of Their Use
  • Antibodies To Oncostatin M Receptor
  • Polypeptide
  • Nucleic Acids Coding For Antibodies Against Human Il-21 Receptor And Uses Therefor
  • Antibodies That Block Receptor Protein Tyrosine Kinase Activation, Methods Of Screening For And Uses Thereof
  • Susceptibility Variants For Lung Cancer
  • Dna Encoding Antibody Molecules Which Bind Il-17a And Il-17f
  • Sgp130/Fc Dimers
  • Modified Polynucleotides For The Production Of Cytoplasmic And Cytoskeletal Proteins
  • Benzocyclooctyne Compounds And Uses Thereof
  • Method For The Diagnosis And Prognosis Of Malignant Diseases
  • Markers Of Definitive Endoderm
  • Encapsulation Of Pancreatic Cells Derived From Human Pluripotent Stem Cells
  • Antibody Fc Variants
  • Chaperonin 10 Variants
  • Methods Of Treating Pain By Inhibition Of Vgf Activity
  • Chimeric Fibroblast Growth Factors With Altered Receptor Specificity
  • Compounds Binding To Jmjd6 With Antifibrotic Activity
  • Human Anti-Alpha-Synuclein Antibodies
  • Mdr E. Coli Specific Antibody
  • Antibodies To Quetiapine Haptens And Use Thereof
  • Anti-Bv8 Antibodies And Uses Thereof
  • Pyrrolobenzodiazepine-Anti-Cd22 Antibody Conjugates
  • Compositions And Methods For Treatment And Detection Of Cancers
  • Methods And Compositions For Generating An Immune Response By Inducing Cd40 And Pattern Recognition Receptor Adapters
  • Compositions Produced Using Enteric Pathogens And Methods Of Use
  • Lymphokine In The Pure State, Monoclonal Antibodies, Hybridoma Cell Lines, Processes And Applications
  • Cd2-Binding Domain Of Lymphocyte Function Associated Antigen 3
  • Use Of Human Protein C For Prevention And Treatment Of Depositions Of Thrombocytes
  • Particle Bound Binding Component Immunoassay
  • Certain Pyridyl And Isoquinolyl Carbinolamine Derivatives
  • Chimeric Protein That Has A Human Rho Motif And Deoxyribonuclease Activity
  • Vaccine For B-Cell Malignancies
  • Egvii Endoglucanase And Nucleic Acids Encoding The Same
  • Hedgehog And Patched Antagonists For Inhibiting Cell And Tissue Growth And Differentiation And Uses Therefor
  • Neutralizing Monoclonal Antibodies To Respiratory Syncytial Virus
  • Cancerous Disease Modifying Antibodies
  • Preparation For Treating And Preventing Thromboses And Thromboembolic Complications, Use Of Such A Preparation And A Method Of Producing The Same
  • Treatment For Inflammatory Bowel Disease With A Vcam-1/1gg Fusion Protein
  • Identification Of Agents That Protect Against Inflammatory Injury To Neurons
  • Assay For Marker Of Human Polymorphonuclear Leukocyte Elastase Activity
  • Pichia Pastoris Formate Dehydrogenase And Uses Therefor
  • Aortic Carboxypeptidase-Like Polypeptide
  • Alternatively Spliced Isoform Of Acetyl-Coa Carboxylase 2 (Acc2)
  • Methods Of Modulating C-Kit Tyrosine Protein Kinase Function With Indolinone Compounds
  • Chondrosarcoma Associated Genes
  • Methods For Treating Post-Surgical Pain By Administering An Anti-Nerve Growth Factor Antagonist Antibody
  • Methods For Improving Heart Function
  • Compositions For Inhibiting Masp-2 Dependent Complement Activation
  • Monoclonal Antibodies That Specifically Block Biological Activity Of A Tumor Antigen
  • Epitopes Related To Coeliac Disease
  • Detecting Lipocalin
  • Determining The Effect Of A Substance On Sequestration, Uptake, And Accumulation Of Amyloid In Brain Cells
  • Zanamivir Phosphonate Congeners With Anti-Influenza Activity And Determining Oseltamivir Susceptibility Of Influenza Viruses
  • Method Of Detecting Axonally-Derived Protein Tau In Patients With Traumatic Cns Injury
  • Interleukin—1 Receptor Antagonist And Uses Thereof
  • Ikaros Isoforms And Mutants
  • Methods Of Modulating Lipid Metabolism And Storage
  • Identification Of A New Member Of The Cytochrome P450 3a (Cyp3a) Gene Family: Cyp3ax
  • Methods For Treating Breast Cancer Using Mammastatin
  • Anti-Ige Antibodies
  • Methods For Diagnostic And/Or Treatment Of Antiphospholipids Antibodies-Related Diseases, And Devices
  • Method Of Diagnosing, Monitoring, Staging, Imaging And Treating Colon Cancer
  • Proteins Encoded By Polynucleic Acids Of Porcine Reproductive And Respiratory Syndrome Virus (Prrsv)
  • Methods And Compositions Of Matter Concerning April/G70, Bcma, Blys/Agp-3 And Taci
  • Methods And Compounds For Modulating Male Fertility
  • Incapacitated Whole-Cell Immunogenic Bacterial Compositions
  • Methods For Treating Conditions Associated With The Accumulation Of Excess Extracellular Matrix
  • Method And Kit For Isolating Dna Probes That Bind To Activated Transcription Factors
  • Linker System For Activating Surfaces For Bioconjugation
  • Polymer Brushes For Immobilizing Molecules To A Surface And Having Water-Soluble Or Water-Dispersible Segments Therein And Probes Bonded Thereto
  • 88kda Tumorigenic Growth Factor And Antagonists
  • Cytokine Receptor And Nucleic Acids Encoding The Same
  • Nitroaromatic Compounds For The Detection Of Hypoxia
  • Canine Factor Viii Gene, Protein And Methods Of Use
  • Mutations Associated With Iron Disorders
  • Androgen-Metabolic Gene Mutations And Prostate Cancer Risk
  • Nucleic Acid Encoding Amyloid Precursor-Like Protein And Uses Thereof
  • Assay Method For Screening For Inhibitors Of Protnf Conversion
  • Intranasal Immunization Against Viral Infection Using Viral Glycoprotein Subunit Vaccine
  • Screening Assays For Compounds
  • Encapsulation Of Pancreatic Cells Derived From Human Pluripotent Stem Cells
  • Anti-Cd74 Immunoconjugates And Methods
  • Enhancement Of Immune Responses By 4-1 Bb-Binding Agents
  • Monospecific Antibodies Against A Subunit Of Fibrinogen
  • Methods For Preventing And Treating Fibrotic Diseases Resulting From Accumulation Of Excess Extracellular Matrix Induced By Tgfβ Using Renin Inhibitors
  • Serum Immunoregulatory Polypeptides And Uses Therefor
  • Method Of Screening For An Agent That Inhibits Mononuclear Phagocyte-Plaque Component Complex Formation
  • Antibodies To Human Cancer Nucleolar Antigen Pl20, Corresponding Cell Lines, And Their Preparation And Use In The Detection Of Human Cancer Cells
  • Monoclonal Antibodies To Anthracyclines
  • Monoclonal Antibodies Specific For Myosin In The Brain
  • Antibodies Binding To Polypeptides Encoded By Developmentally-Regulated Endothelial Cell Locus-1
  • Trichoderma Β-Glucosidase
  • Anticancer Compounds And Methods
  • Nucleic Acid And Amino Acid Sequences For Mammalian Sulfonylurea Receptor
  • Internally Controlled Virion Nucleic Acid Amplification Reaction For Quantitation Of Virion And Virion Nucleic Acid
  • Method Of Diagnosing, Monitoring, Staging, Imaging And Treating Gastrointestinal Cancer
  • Flt4 (Vegfr-3) As A Target For Tumor Imaging And Anti-Tumor Therapy
  • Human Histamine Receptor Of The H3 Subtype
  • Egvii Endoglucanase And Nucleic Acids Encoding The Same
  • Targeted Therapeutic Delivery Of Vitamin D Compounds
  • Human Ovarian Mesothelial Cells And Methods Of Isolation And Uses Thereof
  • Compositions And Methods For Identifying Agents Which Regulate Autolytic Processes In Bacteria
  • Treatment Of Metastatic Disease
  • Sequences Encoding Hepatitis C Virus Glycoproteins
  • Egvi Endoglucanase And Nucleic Acids Encoding The Same
  • Novel Potassium Channel
  • Polynucleotide And Protein Involved In Synaptogenesis Variants Thereof And Their Therapeutic And Diagnostic Uses
  • Polyene Polyketides, Processes For Their Production And Their Use As A Pharmaceutical
  • Antibodies To Paliperidone And Use Thereof
  • Methods And Compositions For The Treatment Of Antibody Mediated Neuropathies
  • Anti-Cxcr4 Antibodies And Their Use For The Treatment Of Cancer
  • Nucleic Acid Molecules Containing Recombination Sites And Methods Of Using The Same
  • Transferrin Binding Proteins From Neisseria Gonorrhoeae And Neisseria Meningitidis
  • Antibodies That Bind To Epha2 And Methods Of Use Thereof
  • Genetically Altered Antibody-Producing Cell Lines With Improved Antibody Characteristics
  • Compositions And Methods In Cancer Associated With Altered Expression Of Prlr
  • Bgl4 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Allergen Microarray
  • B-Type Plexin Antagonists And Uses Thereof
  • Unsolvated Benzodiazepine Compositions And Methods
  • Flt4 (Vegfr-3) As A Target For Tumor Imaging And Anti-Tumor Therapy
  • Influenza Virus Vaccine Composition And Methods Of Use
  • Detection Of Von-Willebrand Factor (Vwf) Activity
  • Influenza Virus Vaccine Composition And Methods Of Use
  • Monoclonal Antibody For App
  • Method For Predicting Responsiveness Of Breast Cancer To Antiestrogen Therapy
  • S. Pneumoniae Antigens
  • Methods For Producing Members Of Specific Binding Pairs
  • Compositions Capable Of Specifically Binding Particular Human Antigen Presenting Molecule/Pathogen-Derived Antigen Complexes And Uses Thereof
  • Immunogenic Epitopes, Peptidomimetics, And Anti-Peptide Antibodies, And Methods Of Their Use
  • Hydrophilic Self-Immolative Linkers And Conjugates Thereof
  • Split Dose Administration
  • Hybrid Cell Line For Producing Complement-Fixing, Monoclonal Antibody To Human Suppressor T Cells, Antibody, Method Of Preparation Of This Antibody, Diagnostic And Therapeutic Uses And Pharmaceutical Compositions Comprising This Antibody
  • Methods And Nucleic Acids For The Analysis Of Gene Expression Associated With The Development Of Prostate Cell Proliferative Disorders
  • Markers Of Definitive Endoderm
  • Methods Of Generating Hybrid/Chimeric Cells, And Uses Thereof
  • Iron-Zinc Binding Control Factor, And Technique For Improving Iron Deficiency Tolerance Of Plant And Enhancing Iron And Zinc Accumulation In Edible Part Thereof By Controlling Expression Of Novel Iron-Zinc Binding Control Factor
  • Combination Therapies Comprising Anti-Erbb3 Agents
  • Methods And Compositions For Detection Of Ehrlichia Chaffeensis (Vlpt)
  • Methods Of Determining Patient Response By Measurement Of Her-3 And P95
  • Antibody Producing Non-Human Mammals
  • Genetic Variants For Breast Cancer Risk Assessment
  • Antibodies That Bind The Glutamate Ligand Binding Region Of Notch3
  • Genetic Susceptibility Variants Associated With Cardiovascular Disease
  • 2,5-Diketo-L-Gluconic Acid Reductases And Methods Of Use
  • Aptamer Therapeutics Useful In The Treatment Of Complement-Related Disorders
  • Adam-9 Modulators
  • Monoclonal Antibodies Reactive With Endotoxin Core.
  • Rat Hepatocyte Monoclonal Antibody In Hepatocarcinogenesis
  • Flattop (Fltp) Is A Novel Biomarker For Beta Cell Maturation
  • Antibody For The Diagnosis And/Or Prognosis Of Cancer
  • Modified Polynucleotides Encoding Aryl Hydrocarbon Receptor Nuclear Translocator
  • Antigen-Presenting Complex-Binding Compositions And Uses Thereof
  • Sorghum Centromere Sequences And Minichromosomes
  • Plants Modified With Mini-Chromosomes
  • Function Of Gpr4 In Vascular Inflammatory Response To Acidosis And Related Methods
  • Histone Deacetylases, And Uses Related Thereto
  • Multivalent Fibronectin Based Scaffold Domain Proteins
  • Methods Of Inducing An Immune Response In A Host By Administering Flavivirus Immunogens Comprising Extracellular Viral Particles Composed Of The Premembrane (Prm) And Envelope (E) Antigens
  • Method Of Treatment Of A Solid Tumor With Interleukin-1 Accessory Protein Antibody
  • Histone Deacetylases, And Uses Related Thereto
  • Monoclonal Antibodies Against Osteopontin
  • Systems And Methods For Generating Images Of Tissue
  • Method Of Detecting Phosphorylation State Of Beta-Catenin
  • Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
  • Novel Cytotoxic Agents For Conjugation Of Drugs To Cell Binding Molecule
  • Exo-Specific Amylase Polypeptides, Nucleic Acids Encoding Those Polypeptides And Uses Thereof
  • Antibodies Recognizing A Carbohydrate Containing Epitope On Cd-43 And Cea Expressed On Cancer Cells And Methods Using Same
  • Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
  • Removal Of A-Scan Streaking Artifact
  • Modified Polynucleotides For The Production Of Proteins Associated With Blood And Lymphatic Disorders
  • Therapeutic Dll4 Binding Proteins
  • A Method For The Production Of Recombinant Monoclonal Antibodies From Memory - B - Lymphocytes
  • Extracellular Matrix Metalloproteinase Inducer (Emmprin) Peptides And Binding Antibodies
  • Means And Methods For Treating Or Preventing Brain Tumors Based On The Nuclear Receptor Tailless (Tix)
  • B7-H1 And Methods Of Diagnosis, Prognosis, And Treatment Of Cancer
  • B7-H1 Antibodies And Method Of Use
  • Deacetylase Inhibitors And Uses Thereof
  • Methods For Treating A Disease Characterized By An Excess Of Hyaluronan By Administering A Soluble Hyaluronidase Glycoprotein (Shasegp)
  • Fgf21 Mutants And Uses Thereof
  • Chimeric Pcsk9 Proteins, Cells Comprising Same, And Assays Using Same
  • Method For Preparation Of Single Chain Antibodies
  • Method To Generate Antibodies To Ion Channels
  • Cell Preparations Depleted Of Tcr Alpha/Beta
  • Dna Encoding Function Modifying Nav1.7 Antibodies
  • Antibodies Inhibiting C-Met Dimerization, And Uses Thereof
  • Antibodies Reactive With B7-H3, Immunologically Active Fragments Thereof And Uses Thereof
  • Monoclonal Antibody Against Human Tau Protein
  • Angiogenesis Inhibiting Molecules, Their Selection, Production And Their Use In The Treatment Of Cancer
  • Bacterial Virulence Factors And Uses Thereof
  • Polynucleotides Encoding Signal Peptide-Containing Molecules
  • Bgl5 Β-Glucosidase And Nucleic Acids Encoding The Same
  • Modified Caspase Polypeptides And Uses Thereof
  • Rapid And Sensitive Method For Detection Of Biological Targets
  • Sequential Oligonucleotide Syntheses Using Immunoaffinity Techniques
  • Nucleotide, Deduced Amino Acid Sequence, Isolation And Purification Of Heat-Shock Chlamydial Proteins
  • Antibodies To Angiogenin: Immunotherapeutic Agents.
  • Anti-Pdgf-C Antibodies
  • Humanized Anti Cxcr4 Antibodies For The Treatment Of Cancer
  • Antibody To Secreted Polypeptide
  • Cell-Based Methods For Coupling Protein Interactions And Binding Molecule Selection And Diversification
  • Production Of Proteins In Glutamine-Free Cell Culture Media
  • Prostate Cancer Diagnosis And Treatment
  • Therapy For Liver Disease
  • Anti-Cd74 Immunoconjugates And Methods
  • Method For The Treatment Of Multiple Sclerosis By Inhibiting Il-17 Activity
  • Multimodal Segmentation In Intravascular Images
  • Human M2e Peptide Immunogens
  • Structural Variants Of Antibodies For Improved Therapeutic Characteristics
  • Tweak Receptor
  • Modified Polynucleotides For The Production Of Biologics And Proteins Associated With Human Disease
  • Composition And Method For The Diagnosis And Treatment Of Iron-Related Disorders
  • Methods For Using Anti-Αvβ3 Integrin Antibody
  • Antibody To Aminoterminal Propeptide Of Type 1 Procollagen
  • Method For Controlling O-Desulfation Of Heparin
  • Monoclonal Antibodies Against Tumor-Associated Antigens, A Process For The Preparation Thereof And The Use Thereof
  • Antigenic Epitopes Present On Membrane-Bound But Not Secreted Iga
  • Hybridomas And Monoclonal Paratopic Molecules To Apolipoprotein A-I
  • Detection Of Antibodies To Squalene In Serum
  • Methods For Producing Members Of Specific Binding Pairs
  • Monoclonal Antibody Against Human Β2-Glycoprotein I And Use Thereof
  • Hybrid Cell Line For Producing Monoclonal Antibody To A Human T Cell Antigen, Antibody, And Methods
  • Anti-Nucleolin Agent-Conjugated Nanoparticles
  • Formulation And Delivery Of Plga Microspheres
  • Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
  • Aptamer Therapeutics Useful In The Treatment Of Complement-Related Disorders
  • Fgf21 Polypeptides Comprising Two Or More Mutations And Uses Thereof
  • Method For Producing And Obtaining Variable Domains Of Anti-Digoxin Monoclonal Antibody Fab Fragment Using The Molecular Biology Cloning Technique
  • Antibodies To Il-1r1
  • Methods For Treating Bone Cancer By Administering A Nerve Growth Factor Antagonist Antibody
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/256495a0

    DOI

    http://dx.doi.org/10.1038/256495a0

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1001387921

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/1172191


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Immunology", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antibody Formation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antibody Specificity", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Fusion", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Line", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Culture Techniques", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Erythrocytes", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Genetic Code", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunoglobulins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice, Inbred BALB C", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Multiple Myeloma", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Spleen", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "familyName": "K\u00d6HLER", 
            "givenName": "G.", 
            "type": "Person"
          }, 
          {
            "familyName": "MILSTEIN", 
            "givenName": "C.", 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/205640a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001120649", 
              "https://doi.org/10.1038/205640a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/205640a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001120649", 
              "https://doi.org/10.1038/205640a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/244042a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1004074762", 
              "https://doi.org/10.1038/244042a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.71.6.2203", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1007851105"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0014-4827(70)90489-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008893882"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/252354a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020752516", 
              "https://doi.org/10.1038/252354a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/219066a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021244471", 
              "https://doi.org/10.1038/219066a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/eji.1830030305", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028187016"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1042/bj1280427", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050611617"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1042/bj1280427", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050611617"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1126/science.140.3565.405", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1062479878"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1126/science.145.3633.709", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1062483252"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1152/physrev.1972.52.3.631", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1080437434"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1975-08", 
        "datePublishedReg": "1975-08-01", 
        "description": "THE manufacture of predefined specific antibodies by means of permanent tissue culture cell lines is of general interest. There are at present a considerable number of permanent cultures of myeloma cells1,2 and screening procedures have been used to reveal antibody activity in some of them. This, however, is not a satisfactory source of monoclonal antibodies of predefined specificity. We describe here the derivation of a number of tissue culture cell lines which secrete anti-sheep red blood cell (SRBC) antibodies. The cell lines are made by fusion of a mouse myeloma and mouse spleen cells from an immunised donor. To understand the expression and interactions of the Ig chains from the parental lines, fusion experiments between two known mouse myeloma lines were carried out.", 
        "genre": "research_article", 
        "id": "sg:pub.10.1038/256495a0", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1018957", 
            "issn": [
              "0090-0028", 
              "1476-4687"
            ], 
            "name": "Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "5517", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "256"
          }
        ], 
        "name": "Continuous cultures of fused cells secreting antibody of predefined specificity", 
        "pagination": "495-497", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "069c499d4bb0d438c6a833161c969c43eb28248be5c0ba53729b77fa0218f92c"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "1172191"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "0410462"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/256495a0"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1001387921"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/256495a0", 
          "https://app.dimensions.ai/details/publication/pub.1001387921"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-10T14:47", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8663_00000421.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "http://www.nature.com/articles/256495a0"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/256495a0'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/256495a0'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/256495a0'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/256495a0'


     

    This table displays all metadata directly associated to this object as RDF triples.

    158 TRIPLES      21 PREDICATES      53 URIs      34 LITERALS      22 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/256495a0 schema:about N0436d2903c1e43348a61ccb4d4b4f6f9
    2 N0b3f10719a3548dab6af720e3a47e7cc
    3 N0f3ef4b7fa004f9dbc9a2a7c5665af42
    4 N21797ef64e254566a179c9f21d0a758e
    5 N26868bc3c0754d429d2e87bfcbde741c
    6 N36a83158762a4a138d34b9e1dadf1b90
    7 N4a3e672ccb604e78a4419f6e9fe99c05
    8 N5cba59067982402395de2633f857d029
    9 N5ecdf257e1924003ae1f900cf40df71a
    10 N971c1d07762048cea28c2a727bfdaf61
    11 Nb98d565115324c26ac3b6df425082267
    12 Nee60ee804aeb4da1b71177bc50003bac
    13 Nfeae8f5cac334727875c88a4f2c3b0d2
    14 anzsrc-for:11
    15 anzsrc-for:1107
    16 schema:author Nab57637cf9144eb4ad006ba6d1d59524
    17 schema:citation sg:pub.10.1038/205640a0
    18 sg:pub.10.1038/219066a0
    19 sg:pub.10.1038/244042a0
    20 sg:pub.10.1038/252354a0
    21 https://doi.org/10.1002/eji.1830030305
    22 https://doi.org/10.1016/0014-4827(70)90489-1
    23 https://doi.org/10.1042/bj1280427
    24 https://doi.org/10.1073/pnas.71.6.2203
    25 https://doi.org/10.1126/science.140.3565.405
    26 https://doi.org/10.1126/science.145.3633.709
    27 https://doi.org/10.1152/physrev.1972.52.3.631
    28 schema:datePublished 1975-08
    29 schema:datePublishedReg 1975-08-01
    30 schema:description THE manufacture of predefined specific antibodies by means of permanent tissue culture cell lines is of general interest. There are at present a considerable number of permanent cultures of myeloma cells1,2 and screening procedures have been used to reveal antibody activity in some of them. This, however, is not a satisfactory source of monoclonal antibodies of predefined specificity. We describe here the derivation of a number of tissue culture cell lines which secrete anti-sheep red blood cell (SRBC) antibodies. The cell lines are made by fusion of a mouse myeloma and mouse spleen cells from an immunised donor. To understand the expression and interactions of the Ig chains from the parental lines, fusion experiments between two known mouse myeloma lines were carried out.
    31 schema:genre research_article
    32 schema:inLanguage en
    33 schema:isAccessibleForFree false
    34 schema:isPartOf Ne401079be4294590a49cadc01ba5d7d4
    35 Nfa80c72f7de246b1b3dfc830ad888a13
    36 sg:journal.1018957
    37 schema:name Continuous cultures of fused cells secreting antibody of predefined specificity
    38 schema:pagination 495-497
    39 schema:productId N7038090ee3e340c88d7825352cd592e3
    40 N72e537dad06e4394b02cb6371efae7b0
    41 N765e3de3bbe445e097e3bea46f2d5fd0
    42 Ne00e1d2ba77e4a3ca6951d88b7a60981
    43 Nf2ee46c5813a46a786ea886a6f6bbe2e
    44 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001387921
    45 https://doi.org/10.1038/256495a0
    46 schema:sdDatePublished 2019-04-10T14:47
    47 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    48 schema:sdPublisher N9d867feb85bd4922bbe42c3caeae5ed3
    49 schema:url http://www.nature.com/articles/256495a0
    50 sgo:license sg:explorer/license/
    51 sgo:sdDataset articles
    52 rdf:type schema:ScholarlyArticle
    53 N0436d2903c1e43348a61ccb4d4b4f6f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    54 schema:name Antibody Formation
    55 rdf:type schema:DefinedTerm
    56 N0b3f10719a3548dab6af720e3a47e7cc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    57 schema:name Mice, Inbred BALB C
    58 rdf:type schema:DefinedTerm
    59 N0f3ef4b7fa004f9dbc9a2a7c5665af42 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    60 schema:name Antibody Specificity
    61 rdf:type schema:DefinedTerm
    62 N12c4e2c823244c208078f0370222dc7c rdf:first Nd2707f2b5f08481ebbe8b0ad7fcda6dc
    63 rdf:rest rdf:nil
    64 N21797ef64e254566a179c9f21d0a758e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    65 schema:name Cell Fusion
    66 rdf:type schema:DefinedTerm
    67 N26868bc3c0754d429d2e87bfcbde741c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    68 schema:name Genetic Code
    69 rdf:type schema:DefinedTerm
    70 N26d620295e40465bb613cc2caf388e47 schema:familyName KÖHLER
    71 schema:givenName G.
    72 rdf:type schema:Person
    73 N36a83158762a4a138d34b9e1dadf1b90 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    74 schema:name Culture Techniques
    75 rdf:type schema:DefinedTerm
    76 N4a3e672ccb604e78a4419f6e9fe99c05 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    77 schema:name Multiple Myeloma
    78 rdf:type schema:DefinedTerm
    79 N5cba59067982402395de2633f857d029 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    80 schema:name Animals
    81 rdf:type schema:DefinedTerm
    82 N5ecdf257e1924003ae1f900cf40df71a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    83 schema:name Immunoglobulins
    84 rdf:type schema:DefinedTerm
    85 N7038090ee3e340c88d7825352cd592e3 schema:name nlm_unique_id
    86 schema:value 0410462
    87 rdf:type schema:PropertyValue
    88 N72e537dad06e4394b02cb6371efae7b0 schema:name doi
    89 schema:value 10.1038/256495a0
    90 rdf:type schema:PropertyValue
    91 N765e3de3bbe445e097e3bea46f2d5fd0 schema:name readcube_id
    92 schema:value 069c499d4bb0d438c6a833161c969c43eb28248be5c0ba53729b77fa0218f92c
    93 rdf:type schema:PropertyValue
    94 N971c1d07762048cea28c2a727bfdaf61 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    95 schema:name Spleen
    96 rdf:type schema:DefinedTerm
    97 N9d867feb85bd4922bbe42c3caeae5ed3 schema:name Springer Nature - SN SciGraph project
    98 rdf:type schema:Organization
    99 Nab57637cf9144eb4ad006ba6d1d59524 rdf:first N26d620295e40465bb613cc2caf388e47
    100 rdf:rest N12c4e2c823244c208078f0370222dc7c
    101 Nb98d565115324c26ac3b6df425082267 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    102 schema:name Cell Line
    103 rdf:type schema:DefinedTerm
    104 Nd2707f2b5f08481ebbe8b0ad7fcda6dc schema:familyName MILSTEIN
    105 schema:givenName C.
    106 rdf:type schema:Person
    107 Ne00e1d2ba77e4a3ca6951d88b7a60981 schema:name dimensions_id
    108 schema:value pub.1001387921
    109 rdf:type schema:PropertyValue
    110 Ne401079be4294590a49cadc01ba5d7d4 schema:issueNumber 5517
    111 rdf:type schema:PublicationIssue
    112 Nee60ee804aeb4da1b71177bc50003bac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    113 schema:name Mice
    114 rdf:type schema:DefinedTerm
    115 Nf2ee46c5813a46a786ea886a6f6bbe2e schema:name pubmed_id
    116 schema:value 1172191
    117 rdf:type schema:PropertyValue
    118 Nfa80c72f7de246b1b3dfc830ad888a13 schema:volumeNumber 256
    119 rdf:type schema:PublicationVolume
    120 Nfeae8f5cac334727875c88a4f2c3b0d2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    121 schema:name Erythrocytes
    122 rdf:type schema:DefinedTerm
    123 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    124 schema:name Medical and Health Sciences
    125 rdf:type schema:DefinedTerm
    126 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
    127 schema:name Immunology
    128 rdf:type schema:DefinedTerm
    129 sg:journal.1018957 schema:issn 0090-0028
    130 1476-4687
    131 schema:name Nature
    132 rdf:type schema:Periodical
    133 sg:pub.10.1038/205640a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001120649
    134 https://doi.org/10.1038/205640a0
    135 rdf:type schema:CreativeWork
    136 sg:pub.10.1038/219066a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021244471
    137 https://doi.org/10.1038/219066a0
    138 rdf:type schema:CreativeWork
    139 sg:pub.10.1038/244042a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004074762
    140 https://doi.org/10.1038/244042a0
    141 rdf:type schema:CreativeWork
    142 sg:pub.10.1038/252354a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020752516
    143 https://doi.org/10.1038/252354a0
    144 rdf:type schema:CreativeWork
    145 https://doi.org/10.1002/eji.1830030305 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028187016
    146 rdf:type schema:CreativeWork
    147 https://doi.org/10.1016/0014-4827(70)90489-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008893882
    148 rdf:type schema:CreativeWork
    149 https://doi.org/10.1042/bj1280427 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050611617
    150 rdf:type schema:CreativeWork
    151 https://doi.org/10.1073/pnas.71.6.2203 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007851105
    152 rdf:type schema:CreativeWork
    153 https://doi.org/10.1126/science.140.3565.405 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062479878
    154 rdf:type schema:CreativeWork
    155 https://doi.org/10.1126/science.145.3633.709 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062483252
    156 rdf:type schema:CreativeWork
    157 https://doi.org/10.1152/physrev.1972.52.3.631 schema:sameAs https://app.dimensions.ai/details/publication/pub.1080437434
    158 rdf:type schema:CreativeWork
     




    Preview window. Press ESC to close (or click here)


    ...